CN103182387B - 防止、去除、减少或破坏生物膜的方法 - Google Patents
防止、去除、减少或破坏生物膜的方法 Download PDFInfo
- Publication number
- CN103182387B CN103182387B CN201210357075.6A CN201210357075A CN103182387B CN 103182387 B CN103182387 B CN 103182387B CN 201210357075 A CN201210357075 A CN 201210357075A CN 103182387 B CN103182387 B CN 103182387B
- Authority
- CN
- China
- Prior art keywords
- amylase
- enzyme
- cellulase
- zymoprotein
- endoglucanase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 89
- 108090000637 alpha-Amylases Proteins 0.000 claims abstract description 103
- 102000004139 alpha-Amylases Human genes 0.000 claims abstract description 103
- 229940024171 alpha-amylase Drugs 0.000 claims abstract description 100
- 102000004190 Enzymes Human genes 0.000 claims description 69
- 108090000790 Enzymes Proteins 0.000 claims description 69
- 229940088598 enzyme Drugs 0.000 claims description 69
- 108010059892 Cellulase Proteins 0.000 claims description 52
- 230000000813 microbial effect Effects 0.000 claims description 38
- 229920002472 Starch Polymers 0.000 claims description 29
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 27
- 229940106157 cellulase Drugs 0.000 claims description 22
- -1 haloperoxidase Proteins 0.000 claims description 22
- 239000008107 starch Substances 0.000 claims description 22
- 235000019698 starch Nutrition 0.000 claims description 22
- 108090001060 Lipase Proteins 0.000 claims description 19
- 102000004882 Lipase Human genes 0.000 claims description 19
- 239000004367 Lipase Substances 0.000 claims description 18
- 235000019421 lipase Nutrition 0.000 claims description 18
- 108010029541 Laccase Proteins 0.000 claims description 15
- 230000002797 proteolythic effect Effects 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 12
- 230000003115 biocidal effect Effects 0.000 claims description 12
- 239000003139 biocide Substances 0.000 claims description 12
- 239000001814 pectin Substances 0.000 claims description 11
- 229920001277 pectin Polymers 0.000 claims description 11
- 235000010987 pectin Nutrition 0.000 claims description 11
- 241001480714 Humicola insolens Species 0.000 claims description 10
- 102000003992 Peroxidases Human genes 0.000 claims description 10
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 108010059820 Polygalacturonase Proteins 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- 108010022999 Serine Proteases Proteins 0.000 claims description 7
- 102000012479 Serine Proteases Human genes 0.000 claims description 7
- 241000223198 Humicola Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- 239000004382 Amylase Substances 0.000 claims description 5
- 241001328122 Bacillus clausii Species 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 101710157860 Oxydoreductase Proteins 0.000 claims description 5
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 5
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 5
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 5
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 5
- 239000000835 fiber Substances 0.000 claims description 5
- 102000013142 Amylases Human genes 0.000 claims description 4
- 108010065511 Amylases Proteins 0.000 claims description 4
- 241000193422 Bacillus lentus Species 0.000 claims description 4
- 108010022172 Chitinases Proteins 0.000 claims description 4
- 102000012286 Chitinases Human genes 0.000 claims description 4
- 108090000371 Esterases Proteins 0.000 claims description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 4
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 4
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 4
- 239000006185 dispersion Substances 0.000 claims description 4
- 108010011619 6-Phytase Proteins 0.000 claims description 3
- 102000004400 Aminopeptidases Human genes 0.000 claims description 3
- 108090000915 Aminopeptidases Proteins 0.000 claims description 3
- 108010006303 Carboxypeptidases Proteins 0.000 claims description 3
- 102000005367 Carboxypeptidases Human genes 0.000 claims description 3
- 108010053835 Catalase Proteins 0.000 claims description 3
- 102000016938 Catalase Human genes 0.000 claims description 3
- 108010031396 Catechol oxidase Proteins 0.000 claims description 3
- 102000030523 Catechol oxidase Human genes 0.000 claims description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 claims description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 claims description 3
- 102100022624 Glucoamylase Human genes 0.000 claims description 3
- 108010054377 Mannosidases Proteins 0.000 claims description 3
- 102000001696 Mannosidases Human genes 0.000 claims description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims description 3
- 108010029182 Pectin lyase Proteins 0.000 claims description 3
- 241001494489 Thielavia Species 0.000 claims description 3
- 108060008539 Transglutaminase Proteins 0.000 claims description 3
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims description 3
- 108010089934 carbohydrase Proteins 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 3
- 235000011073 invertase Nutrition 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229940085127 phytase Drugs 0.000 claims description 3
- 102000003601 transglutaminase Human genes 0.000 claims description 3
- 241001495429 Thielavia terrestris Species 0.000 claims description 2
- 241001468259 Anoxybacillus flavithermus Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 27
- 230000001580 bacterial effect Effects 0.000 description 46
- 239000000243 solution Substances 0.000 description 33
- 244000005700 microbiome Species 0.000 description 25
- 102000035195 Peptidases Human genes 0.000 description 19
- 108091005804 Peptidases Proteins 0.000 description 19
- 241001148470 aerobic bacillus Species 0.000 description 19
- 108090000787 Subtilisin Proteins 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 16
- 241000233866 Fungi Species 0.000 description 16
- 239000000463 material Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 101710081721 Alpha-amylase A Proteins 0.000 description 13
- 239000000203 mixture Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 102000004157 Hydrolases Human genes 0.000 description 10
- 108090000604 Hydrolases Proteins 0.000 description 10
- 241000589516 Pseudomonas Species 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 229920001503 Glucan Polymers 0.000 description 9
- 244000286779 Hansenula anomala Species 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000006150 trypticase soy agar Substances 0.000 description 7
- 229940100445 wheat starch Drugs 0.000 description 7
- 241000228212 Aspergillus Species 0.000 description 6
- 229920002307 Dextran Polymers 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229910001220 stainless steel Inorganic materials 0.000 description 6
- 239000010935 stainless steel Substances 0.000 description 6
- 101710081719 Alpha-amylase B Proteins 0.000 description 5
- 101710128063 Carbohydrate oxidase Proteins 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 101710098556 Lipase A Proteins 0.000 description 5
- 101710099648 Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 5
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 108010018734 hexose oxidase Proteins 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 241000228215 Aspergillus aculeatus Species 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 4
- 229920000018 Callose Polymers 0.000 description 4
- 241001619326 Cephalosporium Species 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 101710156496 Endoglucanase A Proteins 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 241000223221 Fusarium oxysporum Species 0.000 description 4
- 241000813090 Rhizoctonia solani Species 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 101710135785 Subtilisin-like protease Proteins 0.000 description 4
- 241001313536 Thermothelomyces thermophila Species 0.000 description 4
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 230000001461 cytolytic effect Effects 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 230000002538 fungal effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000123 paper Substances 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000607534 Aeromonas Species 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 241000223678 Aureobasidium pullulans Species 0.000 description 3
- 241000194108 Bacillus licheniformis Species 0.000 description 3
- 241000194103 Bacillus pumilus Species 0.000 description 3
- 241000206575 Chondrus crispus Species 0.000 description 3
- 244000251987 Coprinus macrorhizus Species 0.000 description 3
- 235000001673 Coprinus macrorhizus Nutrition 0.000 description 3
- 241000589565 Flavobacterium Species 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 102000005741 Metalloproteases Human genes 0.000 description 3
- 108010006035 Metalloproteases Proteins 0.000 description 3
- 241001467578 Microbacterium Species 0.000 description 3
- 241000226677 Myceliophthora Species 0.000 description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
- 241000223251 Myrothecium Species 0.000 description 3
- 241000203622 Nocardiopsis Species 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 241000223258 Thermomyces lanuginosus Species 0.000 description 3
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 3
- 241000499912 Trichoderma reesei Species 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 230000032770 biofilm formation Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940023064 escherichia coli Drugs 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000001974 tryptic soy broth Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- 241000589220 Acetobacter Species 0.000 description 2
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 2
- 241000203809 Actinomycetales Species 0.000 description 2
- 241001103808 Albifimbria verrucaria Species 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 241000193752 Bacillus circulans Species 0.000 description 2
- 241000194106 Bacillus mycoides Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 241001465180 Botrytis Species 0.000 description 2
- 241000589513 Burkholderia cepacia Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 241000221955 Chaetomium Species 0.000 description 2
- 241000193155 Clostridium botulinum Species 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 241000222356 Coriolus Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000605716 Desulfovibrio Species 0.000 description 2
- 241000605739 Desulfovibrio desulfuricans Species 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 241000588921 Enterobacteriaceae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002444 Exopolysaccharide Polymers 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000014683 Hansenula anomala Nutrition 0.000 description 2
- 241001134659 Lactobacillus curvatus Species 0.000 description 2
- 241000222418 Lentinus Species 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 241000144128 Lichtheimia corymbifera Species 0.000 description 2
- 102100037611 Lysophospholipase Human genes 0.000 description 2
- 108020002496 Lysophospholipase Proteins 0.000 description 2
- 241000221960 Neurospora Species 0.000 description 2
- 241000187654 Nocardia Species 0.000 description 2
- 241000194109 Paenibacillus lautus Species 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 101710096324 Phospholipase A1 Proteins 0.000 description 2
- 241000222640 Polyporus Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000589781 Pseudomonas oleovorans Species 0.000 description 2
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 2
- 241000589614 Pseudomonas stutzeri Species 0.000 description 2
- 241001361634 Rhizoctonia Species 0.000 description 2
- 241000235402 Rhizomucor Species 0.000 description 2
- 241000235527 Rhizopus Species 0.000 description 2
- 241000593344 Rhizopus microsporus Species 0.000 description 2
- 241000190932 Rhodopseudomonas Species 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000203770 Thermoactinomyces vulgaris Species 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 239000004567 concrete Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 239000011490 mineral wool Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000001967 plate count agar Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000004043 trisaccharides Chemical class 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- 150000004823 xylans Chemical class 0.000 description 2
- 229920000032 1,3-beta-D-Xylan Polymers 0.000 description 1
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010025188 Alcohol oxidase Proteins 0.000 description 1
- 101710112892 Alditol oxidase Proteins 0.000 description 1
- 101710199313 Alpha-L-arabinofuranosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000589149 Azotobacter vinelandii Species 0.000 description 1
- 241001112741 Bacillaceae Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 101000641116 Bacillus sp. (strain L7) Levanase Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 206010004173 Basophilia Diseases 0.000 description 1
- 101710204694 Beta-xylosidase Proteins 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- 241001149957 Cladosporium oxysporum Species 0.000 description 1
- 241000222680 Collybia Species 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 241000863390 Dictyoglomus Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 101710166469 Endoglucanase Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000123326 Fomes Species 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 108010015133 Galactose oxidase Proteins 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241000896533 Gliocladium Species 0.000 description 1
- 108010032083 Glucan 1,4-beta-Glucosidase Proteins 0.000 description 1
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
- 101710156134 Hyaluronoglucuronidase Proteins 0.000 description 1
- 241000222342 Irpex Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101710098554 Lipase B Proteins 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 241001330975 Magnaporthe oryzae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101710136501 Mannan endo-1,4-beta-mannosidase Proteins 0.000 description 1
- 241001147496 Mazzaella flaccida Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001467565 Microbacterium imperiale Species 0.000 description 1
- 241001661345 Moesziomyces antarcticus Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 241000625698 Mycogone Species 0.000 description 1
- OVRNDRQMDRJTHS-BKJPEWSUSA-N N-acetyl-D-hexosamine Chemical compound CC(=O)NC1C(O)O[C@H](CO)C(O)C1O OVRNDRQMDRJTHS-BKJPEWSUSA-N 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 241000203619 Nocardiopsis dassonvillei Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 1
- 241001523956 Parengyodontium album Species 0.000 description 1
- 241001507683 Penicillium aurantiogriseum Species 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000222395 Phlebia Species 0.000 description 1
- 241000222397 Phlebia radiata Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 241000221945 Podospora Species 0.000 description 1
- 241000789035 Polyporus pinsitus Species 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 101710148480 Putative beta-xylosidase Proteins 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
- 240000005384 Rhizopus oryzae Species 0.000 description 1
- 241001148569 Rhodothermus Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
- 244000007853 Sarothamnus scoparius Species 0.000 description 1
- 241000122799 Scopulariopsis Species 0.000 description 1
- 241000223255 Scytalidium Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 241000228391 Sporidiobolus pararoseus Species 0.000 description 1
- 241001279361 Stachybotrys Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 241000948169 Streptomyces viridosporus Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 101710173714 Subtilisin amylosacchariticus Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000228182 Thermoascus aurantiacus Species 0.000 description 1
- 241001291204 Thermobacillus Species 0.000 description 1
- 241000203780 Thermobifida fusca Species 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- 241000204652 Thermotoga Species 0.000 description 1
- 244000044283 Toxicodendron succedaneum Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 241000217816 Trametes villosa Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- FTNIPWXXIGNQQF-UHFFFAOYSA-N UNPD130147 Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 101710158370 Xylan 1,4-beta-xylosidase Proteins 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 229940075612 bacillus cereus Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010035613 beta-D-fucosidase Proteins 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000003876 biosurfactant Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 108010059485 brain synaptic membrane glycoprotein gp 50 Proteins 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- GSPKZYJPUDYKPI-UHFFFAOYSA-N diethoxy sulfate Chemical compound CCOOS(=O)(=O)OOCC GSPKZYJPUDYKPI-UHFFFAOYSA-N 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000002320 enamel (paints) Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 108010058100 fructan beta-fructosidase Proteins 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000002573 hemicellulolytic effect Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FJCUPROCOFFUSR-UHFFFAOYSA-N malto-pentaose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 FJCUPROCOFFUSR-UHFFFAOYSA-N 0.000 description 1
- FJCUPROCOFFUSR-GMMZZHHDSA-N maltopentaose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)O)[C@@H](CO)O1 FJCUPROCOFFUSR-GMMZZHHDSA-N 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229940031815 mycocide Drugs 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 108020004410 pectinesterase Proteins 0.000 description 1
- 230000002351 pectolytic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 108010001816 pyranose oxidase Proteins 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- FCBUKWWQSZQDDI-UHFFFAOYSA-N rhamnolipid Chemical compound CCCCCCCC(CC(O)=O)OC(=O)CC(CCCCCCC)OC1OC(C)C(O)C(O)C1OC1C(O)C(O)C(O)C(C)O1 FCBUKWWQSZQDDI-UHFFFAOYSA-N 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 108010079522 solysime Proteins 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229940037645 staphylococcus epidermidis Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 108010031354 thermitase Proteins 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 150000008496 α-D-glucosides Chemical class 0.000 description 1
- 150000008498 β-D-glucosides Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B17/00—Methods preventing fouling
- B08B17/02—Preventing deposition of fouling or of dust
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B7/00—Cleaning by methods not provided for in a single other subclass or a single group in this subclass
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B9/00—Cleaning hollow articles by methods or apparatus specially adapted thereto
- B08B9/02—Cleaning pipes or tubes or systems of pipes or tubes
- B08B9/027—Cleaning the internal surfaces; Removal of blockages
- B08B9/032—Cleaning the internal surfaces; Removal of blockages by the mechanical action of a moving fluid, e.g. by flushing
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22004—Bromelain (3.4.22.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/2404—Serralysin (3.4.24.40)
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2303/00—Specific treatment goals
- C02F2303/20—Prevention of biofouling
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
- C02F2305/04—Surfactants, used as part of a formulation or alone
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F3/00—Biological treatment of water, waste water, or sewage
- C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
- C02F3/342—Biological treatment of water, waste water, or sewage characterised by the microorganisms used characterised by the enzymes used
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/14—Hard surfaces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mechanical Engineering (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
本发明涉及防止、去除、减少或破坏生物膜的方法,具体的涉及防止、去除、减少或破坏表面上的生物膜的方法,包括使所述表面与来自细菌的α-淀粉酶接触。
Description
本发明是申请日为2005年09月07日,申请号为“200580030095.0”(国际申请号为PCT/US2005/031813),名称为“防止、去除、减少或破坏生物膜的方法”的发明专利申请的分案申请。
相关申请的交叉引用
本申请要求2004年9月8日提交的名为“防止、去除、减少或破坏生物膜的方法”的美国临时申请(序号60/608,535)的优先权,在此将其并入作为参考。
发明领域
本申请涉及防止、去除、减少或破坏表面上的生物膜生成的方法。
发明背景
生物膜(biofilms)是产生并持续存在于含水环境中的生物或非生物性物体表面上的生物膜,它是微生物细胞吸附到所述固体表面上造成的。这种吸附使这些微生物具有竞争优势,因为它们能够繁殖,能够获得更多样的营养物和氧条件,不被冲走,而且对抗微生物剂的敏感性降低。生物膜的形成还伴随着外泌性(exo-)聚合物质(多糖、聚糖醛酸、藻酸盐、糖蛋白和蛋白质)的产生,其与细胞一道形成由充水的空间分隔的厚层的分化结构。居留的微生物可以是单个物种的微生物细胞,或者是微生物细胞的混合群落,这些微生物细胞可包括好氧和厌氧的细胞,藻类、原生动物,和真菌。因此,生物膜是活的微生物的复杂的集合,这些微生物被包埋在由居留的微生物分泌的一种或多种基质聚合物所构成的有机结构中。
生物膜可发展为厚达数毫米或厘米,并覆盖广大表面区域的宏观结构。这些形成物可能是管道系统中限制或完全阻断流动,热交换器中减少热传递,或在城市供水系统、食品加工、医疗设备(例如导管、整形外科设备、植入物、内窥镜)中造成病原性问题的因素。另外,生物膜通过其包埋的微生物介导的腐蚀作用经常缩短材料的寿命。在工业水处理系统、纸浆和纸生产过程、冷却水系统、油回收用的注入井、冷却塔、多孔介质(砂和土壤)、海洋环境、空调系统,以及任何封闭的水再循环系统中,生物结垢(biologicalfouling)是严重的经济性问题。在医疗科学和工业中,生物膜也是严重的问题,其造成牙垢(dentalplaques)、感染(Costerton,1999等人,Science284:1318-1322),内窥镜和隐形眼镜污染,假体装置的定殖(colonisation),及医用植入物上生物膜的形成。
常规上,去除或防止生物膜需要使用分散剂、表面活性剂、去污剂、酶制剂、抗微生物剂(anti-microbials)、杀生物剂(biocides)、煮沸(boil-out)方法,和/或腐蚀性化学品,例如碱。使用这些手段的方法是本领域公知的。例如,在纸浆和造纸工业中,去除造纸机中的生物膜积聚常规上需要沉积物控制程序(depositcontrolprogram),包括合理的保养(housekeeping),以保持表面上没有溅上的原料,对新鲜的水和添加物作抗微生物处理,使用杀生物剂减少机器上的微生物生长,和按方案进行煮沸以去除确实产生的沉积物。
在生物膜中生长的细菌对抗生素和消毒剂的抗性比浮游的细胞更强,而且该抗性随着生物膜的年龄而增加。生物膜还对干燥、极端温度或光显示更高的物理抗性。如已提到的,生物膜的形成造成工业上、环境上和医学上的问题,而且在很多产业中,用化学品清除和消毒细菌生物膜是人们十分关心的问题。另外,消毒和清洁组合物趋向变得更温和,以减轻其环境影响,这样可能使得对覆盖生物膜的表面的清洁更加不足。
本发明的目的是提供防止或去除表面上存在的生物膜的改进的方法。
附图说明
图1显示三种不同的α-淀粉酶对粗小麦淀粉的总水解的百分率(%)的比较。
图2是比较1)α-淀粉酶A;2)单独的去污剂;3)α-淀粉酶C的生物膜去除的色谱图。
发明概述
本发明涉及防止、去除、减少或破坏表面上的生物膜的方法,包括使所述表面与来自细菌的α-淀粉酶接触。
术语“表面”在本文中定义为任何可能被生物膜覆盖或倾向于形成生物膜的表面。表面的例子包括:任何硬表面,例如金属、塑料、橡胶、板、玻璃、木、纸、混凝土、岩石、大理石、石膏和陶瓷材料,这些材料可选地被包被,例如用油漆或瓷漆包被;任何软表面,例如任何种类的纤维(例如纱线、织物、植物纤维、矿棉(rockwool)和毛);或任何多孔表面;皮肤(人或动物的);角质材料(例如甲(nails));和内部器官(例如肺)。所述硬表面可以作为冷却塔、水处理设备、水槽、乳品间(dairy)、食品加工设备、化学或制药过程设备,或医疗装置(例如导管、整形外科装置、植入物)的部分存在。多孔表面可以存在于滤器,例如膜滤器中。
术语“有效量”在本文中定义为足以降解由微生物所产生且包含α-1,4-葡糖苷键的生物膜的一种或多种α-淀粉酶的量。一种或多种α-淀粉酶的有效量依赖于包括下列的因素:所述α-淀粉酶,目标是否是防止、去除或减少表面上存在的生物膜,和用来例如降解微生物产生的生物膜的所希望的时间。一般而言,较高量/浓度的酶需要较短的处理时间,而较低量/浓度的酶需要较长的处理时间。另外,例如,在易于形成生物膜的表面上防止生物膜通常比从相应的污染的表面上实际去除生物膜需要更低量/浓度的酶。但是,典型的有效使用水平是0.005到500mgα-淀粉酶蛋白每升生物膜控制溶液,优选0.01-100mg酶蛋白每升生物膜控制溶液。术语“生物膜控制溶液”是指根据本发明用于防止、去除、减少或破坏表面上存在的生物膜的溶液。以下面实施例4给出的条件下的平均平板计数计,本发明的方法可使生物膜减少到10-108分之一(10-108-fold),优选103-106分之一。
具体地,本发明涉及如下各项:
1.一种防止、去除、减少或破坏表面上存在的生物膜的方法,包括使表面与源自细菌的α-淀粉酶接触。
2.项1的方法,其中所述α-淀粉酶源自芽孢杆菌属的菌株,优选来自芽孢杆菌属菌种NCIB12289,NCIB12512,NCIB12513或DSM9375,或DSMZno.12649,KSMAP1378,或KSMK36或KSMK38的菌株。
3.项2的方法,其中所述α-淀粉酶源自具有SEQIDNO:2,4或6中所示序列的芽孢杆菌属菌株,或者与SEQIDNO:2,4或6具有60%同一性的α-淀粉酶。
4.项2或3的方法,其中所述芽孢杆菌属α-淀粉酶在D183和/或G184位置(SEQIDNO:2中)具有缺失。
5.项3或4的方法,其中所述芽孢杆菌属α-淀粉酶在N195F位置(SEQIDNO:2中)具有取代。
6.项2-5中任一项的方法,其中所述芽孢杆菌属α-淀粉酶在D183+G184位置具有缺失,优选其中所述芽孢杆菌属α-淀粉酶变体还具有一种或多种下列的取代:R118K,N195F,R320K,R458K,特别是其中所述α-淀粉酶具有下面的突变:
Δ(D183+G184)+R118K+N195F+R320K+R458K(在SEQIDNO:2中)。
7.项1的方法,其中使被生物膜污染或易于产生生物膜的表面接触1分钟到2天。
8.项1到7中任一项的方法,其中还存在表面活性剂。
9.项1到8中任一项的方法,其中所述α-淀粉酶在其N末端氨基酸区域中包含Asn-Gly-Thr-Met-Met-Gln-Tyr-Phe-Glu-Trp。
10.项1到9中任一项的方法,其中所述α-淀粉酶以0.005-500mg酶蛋白,优选0.01-100mg酶蛋白每升生物膜控制溶液的浓度使用。
11.项1到10中任一项的方法,其中所述α-淀粉酶在40℃、3mg酶蛋白每g淀粉、pH8.0下5小时后,具有高于15,优选25,特别是35的水解淀粉百分率(%)。
12.项1到11中任一项的方法,其中还存在其它的酶,这些酶选自:氨肽酶、淀粉酶、糖酶、羧肽酶、过氧化氢酶、纤维素酶、几丁质酶、角质酶、环糊精糖基转移酶、脱氧核糖核酸酶、酯酶、α-半乳糖苷酶、β-半乳糖苷酶、葡糖淀粉酶、α-葡萄糖苷酶、β-葡萄糖苷酶、卤素过氧化物酶、转化酶、漆酶、脂肪酶、甘露糖苷酶、氧化还原酶、果胶分解酶、肽谷氨酰胺酶、过氧化物酶、肌醇六磷酸酶、多酚氧化酶、蛋白水解酶、核糖核酸酶、转谷氨酰胺酶或木聚糖酶。
13.项12的方法,其中所述果胶分解酶选自果胶反式消除酶(pectintranseliminase)、多聚半乳糖醛酸酶、果胶酯酶。
14.项13的方法,其中所述纤维素酶是多组分纤维素酶制剂或内切葡聚糖酶,优选腐质霉属(Humicola)内切葡聚糖酶,特别是特异腐质霉(Humicolainsolens)内切葡聚糖酶,更优选来自特异腐质霉DSM1800的EGI或EGV内切葡聚糖酶或其变体或内切葡聚糖酶,优选梭孢壳属(Thielavia)内切葡聚糖酶,优选土生梭孢霉(Thielaviaterrestris)内切葡聚糖酶,或其变体。
15.项12的方法,其中所述果胶分解酶是蛋白酶,优选丝氨酸蛋白酶,特别是源自芽孢杆菌属菌株,例如迟缓芽孢杆菌或克劳氏芽孢杆菌(Bacillusclausii),或其变体。
16.项1-15中任一项的方法,其中还存在选自分散剂、表面活性剂、抗微生物剂和杀生物剂的一种或多种试剂。
17.项1-16中任一项的方法,其中所述表面是硬、软或多孔表面。
18.项18的方法,其中所述表面是膜(membrane)。
19.项1-18中任一项的方法,其中所述生物膜去除是在10-70℃,优选40-60℃的温度下进行的。
20.α-淀粉酶在防止或去除表面的生物膜中的用途。
21.项20的用途,其中所述α-淀粉酶是项1-19中任一项定义的α-淀粉酶。
22.项20或21的用途,其中使用项1-19中定义的其它酶和试剂。
发明详述
本发明涉及防止、去除、减少或破坏表面上的生物膜的改进方法,包括使所述表面与如下定义的有效量的α-淀粉酶接触。本发明的方法可以用来防止、去除、减少或破坏表面上的生物膜形成。本领域的一般技术人员将认识到,这样的方法可以在生物膜形成的不同阶段使用。
通过对表面使用有效量的α-淀粉酶,生物膜的防止和/或去除得到了改善,特别是当生物膜中的某些微生物产生α-1,4连接的葡萄糖多糖,例如直链淀粉、支链淀粉、这两种多糖的混合物(例如淀粉)、和糖原时。
本发明的第一个方面涉及一种防止或去除表面上的生物膜的方法,包括使该表面与源自细菌的α-淀粉酶接触。在一个优选的实施方案中,所述细菌α-淀粉酶来自芽孢杆菌属(Bacillus)。
α-淀粉酶
根据本发明所使用的α-淀粉酶来自细菌,优选来自芽孢杆菌属菌种的菌株,特别是选自:WO00/60060中作为SEQIDNO:2公开的AA560α-淀粉酶(本文的SEQIDNO:2),美国专利申请10/877,847中公开的黄热芽孢杆菌,WO95/26397中公开的芽孢杆菌属菌种的α-淀粉酶,来自芽孢杆菌属菌种NCIB12289,NCIB12512,NCIB12513,DSM9375,DSMZno.12649,KSMAP1378(WO97/00324),KSMK36或KSMK38(EP1022334)的α-淀粉酶,和Tsukamoto等人,BiochemicalandBiophysicalResearchCommunications,151(1988),pp.25-31所公开的#707α-淀粉酶。
在本发明的一个优选的具体实施方案中,所述α-淀粉酶是本文SEQIDNO:2的中所示的AA560α-淀粉酶和/或本文SEQIDNO:4中所示的AMY1048α-淀粉酶,或与本文SEQIDNO:2或4所示的任何序列具有至少60%,优选至少70%,更优选至少80%,更优选至少90%,例如至少95%,至少96%,至少97%,至少98%或至少99%的同一性程度的α-淀粉酶。
在一个优选的实施方案中,所用的α-淀粉酶是作为亲本的本文中SEQIDNO:2所公开的α-淀粉酶的变体,其在D183和/或G184位置具有缺失,优选其中所述α-淀粉酶变体还含有在N195F位置或相应的位置上具有取代,特别是其中亲本α-淀粉酶在本文SEQIDNO:2中具有一种或多种下列的缺失/取代:Δ(R81-G182);Δ(D183-G184);Δ(D183-G184)+N195F;R181Q+N445Q+K446N;Δ(D183-G184)+R181Q,Δ(D183-G184)和一种或多种下列的取代:R118K,N195F,R320K,R458K,特别是其中所述亲本α-淀粉酶具有下列突变:
Δ(D183+G184)+R118K+N195F+R320K+R458K(即,在本文的SEQIDNO:2中)。
在另一个优选的实施方案中,所述α-淀粉酶是SEQIDNO:2中所示的AA560α-淀粉酶,或其变体,该变体还含有一种或多种下列的取代:M9L,M202L,V214T,M323T,M382Y或M9L,M202L,V214T,M323T和E345R。
在一个优选的实施方案中,所述α-淀粉酶在40℃、3mg酶蛋白每g淀粉,pH8.0下5小时后的水解粗淀粉百分率(%)高于15,优选25,特别是35(见实施例2和图1)。
在另一个优选的实施方案中,所述α-淀粉酶在其N末端氨基酸区域中包含Asn-Gly-Thr-Met-Met-Gln-Tyr-Phe-Glu-Trp。这样的α-淀粉酶的例子包括实施例2中使用的α-淀粉酶A和α-淀粉酶B。
在一个实施方案中所述α-淀粉酶来自地衣芽孢杆菌(Bacilluslicheniformis)的菌株,其序列如本文SEQIDNO:6所示;或者是与本文SEQIDNO:6所示的任何序列具有至少60%,优选至少70%,更优选至少80%,更优选至少90%,例如至少95%,至少96%,至少97%,至少98%或至少99%的同一性程度的α-淀粉酶,优选在对应于M197位的位置上具有取代,优选M197L,T,I,N,D,Q,E,P,W,特别是M197L或T。
可商购的α-淀粉酶产品或包含α-淀粉酶的产品包括以下列商品名出售的产品:STAINZYMETM,DURAMYLTM(NovozymesA/S,丹麦),BIOAMYLASED(G),BIOAMYLASETML(BioconIndiaLtd.),KEMZYMTMAT9000(BiozymGes.m.b.H,奥地利),PURASTARTMST,PURASTARTMHPAmL,PURAFECTTMOxAm,RAPIDASETMTEX(GenencorInt.Inc,美国),KAM(KAO,日本)。
在优选的实施方案中,可以在生成任何生物膜之前对易于产生生物膜的表面使用本发明的方法作为预防性手段,从而没有生物膜生成。或者,在出现生物膜生成的最初征象时,可以使用所述方法来防止进一步的生成,并去除已经沉积在表面上的生物膜。另外,在表面上积聚了大量生物膜的情况下,可以使用所述方法来降低生物膜的水平,或部分地或全部地去除它。
生物膜可包含一种或两种微生物的整体化的群落,或者主要包含某种特定的微生物(Palmer和White,1997,TrendsinMicrobiology5:435-440;Costerton等人,1987,AnnualReviewsofMicrobiology41:435-464;Mueller,1994,TAPPIProceedings,1994BiologicalSciencesSymposium195-201)。在本发明的方法中,所述一种或多种微生物可以是任何参与生物膜形成的微生物,包括但不限于,好氧细菌或厌氧细菌(革兰氏阳性和革兰氏阴性)、真菌(酵母或丝状真菌)、藻类、和/或原生动物。考虑到的细菌包括选自下列的细菌:假单胞菌属(Pseudomonas)的一些种,包括铜绿假单胞菌(Pseudomonasaeruginosa);维涅兰德固氮菌(Azotobactervinelandii);大肠杆菌(Escherichiacoli);白喉棒杆菌(Corynebacteriumdiphteriae);肉毒梭菌(Clostridiumbotulinum);链球菌属(Streptococcus)的一些种;醋杆菌属(Acetobacter);明串珠菌属(Leuconostoc);贝塔杆菌属(Betabacterium);肺炎球菌属(Pneumococci);结核分枝杆菌(Mycobacteriumtuberculosis);气单胞菌属(Aeromonas);伯克霍尔德氏菌属(Burkholderie);黄杆菌属(Flavobacterium);沙门氏菌属(Salmonella);葡萄球菌属(Staphylococcus)。
在一个优选的实施方案中,所述微生物是好氧细菌。在一个更优选的实施方案中,所述好氧细菌是气单胞菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是伯克霍尔德氏菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是黄杆菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是微杆菌属(Microbacterium)菌株。在另一个更优选的实施方案中,所述好氧细菌是假单胞菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是沙门氏菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是葡萄球菌属菌株。在另一个更优选的实施方案中,所述好氧细菌是来自肠杆菌科(Enterobacteriaceae)(包括例如大肠杆菌)。
在一个最优选的实施方案中,所述好氧细菌为洋葱伯克霍尔德氏菌(Burkholderiecepacia)。在另一个最优选的实施方案中,所述好氧细菌为蛾微杆菌(Microbacteriumimperiale)或结核分枝杆菌。在另一个最优选的实施方案中,所述好氧细菌为铜绿假单胞菌。在另一个最优选的实施方案中,所述好氧细菌为荧光假单胞菌(Pseudomonasfluorescens)。在另一个最优选的实施方案中,所述好氧细菌为食油假单胞菌(Pseudomonasoleovorans)。在另一个最优选的实施方案中,所述好氧细菌为类产碱假单胞菌(Pseudomonaspseudoalcaligenes)。在另一个最优选的实施方案中,所述好氧细菌为肠炎沙门氏菌(Salmonellaenteritidis)。在另一个最优选的实施方案中,所述好氧细菌为金黄色葡萄球菌(Staphylococcusaureus)。在另一个最优选的实施方案中,所述好氧细菌为表皮葡萄球菌(Staphylococcusepidermidis)。
在另一个优选的实施方案中,所述微生物是厌氧细菌。在另一个更优选的实施方案中,所述厌氧细菌是脱硫弧菌属(Desulfovibrio)菌株。在另一个最优选的实施方案中,所述厌氧细菌是脱硫脱硫弧菌(Desulfovibriodesulfuricans)。
在另一个优选的实施方案中,所述微生物是真菌例如酵母或丝状真菌。在另一个优选的实施方案中,所述酵母是假丝酵母(Candida)菌株。在另一个最优选的实施方案中,所述酵母是白色假丝酵母(Candidaalbicans)。
如上所述的,防止或去除生物膜的处理时间取决于α-淀粉酶的剂量、表面上的或所述区域倾向形成的生物膜的水平,但优选地,所述处理时间应该与用抗生素、杀生物剂、杀菌剂(bactericides)、杀真菌剂(fungicides)、漂白剂(bleachingagents)、表面活性剂(surfactants)、腐蚀剂(caustic)合伙生物聚合物降解剂进行常规处理所正常使用的时间相适应。因此,α-淀粉酶的剂量可以根据常规处理中所用的时间来调节。但是,当α-淀粉酶处理是加工中的单独的步骤时,α-淀粉酶的剂量取决于完成处理所希望的时间。
从α-淀粉酶活性方面来说,防止或去除生物膜的合适的α-淀粉酶剂量表面上的或所述区域倾向形成的生物膜的量。技术人员可决定合适的α-淀粉酶单位剂量。该剂量可以表示为α-淀粉酶单位。α-淀粉酶单位可作为“KNU”测定,使用下面的“材料和方法”部分描述的测定方法。被生物膜污染的或易于产生生物膜的区域优选以0.005到500mgα-淀粉酶蛋白每升生物膜控制溶液,优选0.01到100mgα-淀粉酶蛋白每升生物膜控制溶液的α-淀粉酶剂量处理1分钟到2天,优选10分钟到1天,优选1到15小时,更优选少于10小时。
所述α-淀粉酶可以是本发明的方法中要使用的组合物的部分。所述组合物可以是任何适于所述用途的形式,例如,干粉、聚结粉末(agglomeratedpowder),或颗粒(granulate),特别是非粉化(non-dusting)颗粒,液体,特别是稳定化的液体,或被保护的α-淀粉酶。颗粒和聚结粉末可以用常规方法制备,例如通过在流化床制粒机中将α-淀粉酶喷雾到载体上。所述载体可由具有合适粒度的颗粒物核心(particulatecore)组成。载体可以是可溶的或不可溶的,例如,盐(例如氯化钠或硫酸钠),糖(例如蔗糖或乳糖),糖醇(例如山梨糖醇),或淀粉。α-淀粉酶可包含于缓释制剂中。制备缓释制剂的方法是本领域公知的。液体α-淀粉酶制备可以,例如,根据已建立的方法,通过加入营养上可接受的稳定剂诸如糖、糖醇或另一多元醇,和/或乳酸或另一有机酸来稳定化。
该组合物还可添加一种或多种防止或去除生物膜生成的药剂。这些药剂可包括,但不限于,分散剂、表面活性剂、去污剂、其它的酶,抗微生物剂,和杀生物剂。
在一个优选的实施方案中,所述药剂是表面活性剂。所述表面活性剂可以是非离子型包括半极性和/或阴离子型和/或两性离子型的表面活性剂。
所考虑的阴离子表面活性剂包括线性苯磺酸烷基酯、α-烯属磺酸酯、硫酸烷基酯(脂肪醇硫酸酯)、脂肪醇乙氧基硫酸盐、二级链烷磺酸盐、α-磺基脂肪酸甲酯、烷基或烯基琥珀酸或肥皂。
所考虑的非离子表面活性剂包括脂肪醇乙氧基化物、壬基苯酚乙氧基化物、烷基多苷、烷基二甲基胺氧化物、乙氧基化脂肪酸单乙醇胺、脂肪酸单乙醇胺、多羟基烷基脂肪酰胺、或葡糖胺(“葡萄糖胺”(“glucamides”))的N-酰基N-烷基衍生物。
表面活性剂的可以以所述酶生物膜去除组合物的重量的0.1%到60%的水平存在。
在更优选的实施方案中,所述表面活性剂是十二烷基硫酸钠、季铵化合物、溴化烷基吡啶(alkylpyridiniumiodides),Tween80,Tween,85,TritonX-100,Brij56,生物表面活性剂、鼠李糖脂、表面活性蛋白、visconsin或磺酸盐或酯(sulfonates)。
生物膜的形成还伴随产生外泌性聚合物质(多糖、聚糖醛酸、藻酸盐、糖蛋白和蛋白质),其与细胞一道形成由充水的空间分隔的厚层的分化结构(McEldowney和Fletcher,1986,JournalofGeneralMicrobiology132:513-523;Sutherland,SurfaceCarbohydratesoftheProkaryoticCell,AcademicPress,NewYork,1977,pp.27-96)。在本发明的方法中,所述α-淀粉酶组合物可以还包含一种或多种能够降解所述外泌性聚合物质例如多糖、聚糖醛酸、藻酸盐、糖蛋白和蛋白质的其它的酶。
其它的酶活性
在一个优选的实施方案中,所述一种或多种其它的酶可选自氨肽酶、淀粉酶、糖酶、羧肽酶、过氧化氢酶、纤维素酶、几丁质酶、角质酶、环糊精糖基转移酶、脱氧核糖核酸酶、酯酶、α-半乳糖苷酶、β-半乳糖苷酶、葡糖淀粉酶、α-葡萄糖苷酶、β-葡萄糖苷酶、卤素过氧化物酶、转化酶、氧化酶,包括糖氧化酶、过氧化物酶、漆酶、脂肪酶、甘露糖苷酶、果胶分解酶、肽谷氨酰胺酶、肌醇六磷酸酶、多酚氧化酶、蛋白水解酶、核糖核酸酶、转谷氨酰胺酶或木聚糖酶。
所述其它的酶可根据要去除的特定生物膜的性质来选择,或者可以选择具有不同酶活性的数种酶的组合。
在优选的实施方案中,所述其它酶选自:1,2-1,3-α-D-甘露聚糖甘露糖水解酶(1,2-1,3-alpha-D-mannanmannohydrolase),1,3-β-D-木聚糖木聚糖水解酶(1,3-beta-D-xylanxylanohydrolase),1,3-β-D-葡聚糖葡聚糖水解酶(1,3-beta-D-glucanglucanohydrolase),1,3(1,3;1,4)-α-D-葡聚糖3-葡聚糖水解酶(1,3(1,3;1,4)-alpha-D-glucan3-glucanohydrolase),1,3(1,3;1,4)-β-D-葡聚糖3(4)-葡聚糖水解酶(1,3(1,3;1,4)-beta-D-glucan3(4)-glucanohydrolase),1,3-1,4-α-D-葡聚糖4-葡聚糖水解酶(1,3-1,4-alpha-D-glucan4-glucanohydrolase),1,4-α-D-葡聚糖葡聚糖水解酶(1,4-alpha-D-glucanglucanehydrolase),1,4-α-D-葡聚糖葡萄糖水解酶(1,4-alpha-D-glucanglucohydrolase),1,4-(1,3:1,4)-β-D-葡聚糖4-葡聚糖水解酶(1,4-(1,3:1,4)-beta-D-glucan4-glucanohydrolase),1,4-β-D-葡聚糖葡萄糖水解酶(1,4-beta-D-glucanglucohydrolase),1,4-β-D-木聚糖木聚糖水解酶(1,4-beta-D-xylanxylanohydrolase),1,4-β-D-甘露聚糖甘露聚糖水解酶(1,4-beta-D-mannanmannanohydrolase),1,5-α-L-阿聚糖1,5-α-L-阿聚糖水解酶(1,5-alpha-L-arabinan1,5-alpha-L-arabinanohydrolase),1,4-α-D-葡聚糖麦芽糖水解酶(1,4-alpha-D-glucanmaltohydrolase),1,6-α-D-葡聚糖6-葡聚糖水解酶(1,6-alpha-D-glucan6-glucanohydrolase),2,6-β-D-果聚糖果聚糖水解酶(2,6-beta-D-fructanfructanohydrolase),α-糊精6-葡聚糖水解酶(alpha-Dextrin6-glucanohydrolase),α-D-半乳糖苷半乳糖水解酶(alpha-D-galactosidegalactohydrolase),α-D-葡糖苷葡萄糖水解酶(alpha-D-glucosideglucohydrolase),α-D-甘露糖苷甘露糖水解酶(alpha-D-mannosidemannohydrolase),酰基神经氨酰水解酶(acylneuraminylhydrolase),气杆菌(Aerobacter)-荚膜多糖半乳糖水解酶(Aerobacter-capsular-polysaccharidegalactohydrolase),β-D-呋喃果糖苷果糖水解酶(beta-D-fructofuranosidefructohydrolase),β-D-岩藻糖苷岩藻糖水解酶(beta-D-fucosidefucohydrolase),β-D-果聚糖果糖水解酶(beta-D-fructanfructohydrolase),β-D-半乳糖苷半乳糖水解酶(beta-D-galactosidegalactohydrolase),β-D-葡糖苷葡萄糖水解酶(beta-D-glucosideglucohydrolase),β-D-葡糖醛酸苷葡糖醛酸苷水解酶(beta-D-glucuronosideglucuronosohydrolase),β-D-甘露糖苷甘露糖水解酶(beta-D-mannosidemannohydrolase),β-N-乙酰-D-氨基己糖苷N-乙酰己糖胺水解酶(beta-N-acetyl-D-hexosaminideN-acetylhexosaminohydrolase,),硫酸纤维素磺基水解酶(cellulose-sulfatesulfohydrolase),胶原酶(collagenase),糊精6-α-D-葡聚糖水解酶(dextrin6-alpha-D-glucanohydrolase),糖蛋白-磷脂酰肌醇磷脂酰水解酶(glycoprotein-phosphatidylinositolphosphatidohydrolase),透明质酸4-聚糖水解酶(hyaluronate4-glycanohydrolase),透明质酸葡糖醛酸糖苷酶(hyaluronoglucuronidase),果胶果胶酰水解酶(pectinpectylhydrolase),肽聚糖N-乙酰胞壁酰水解酶(peptidoglycanN-acetylmuramoylhydrolase),磷脂酰胆碱2-酰基水解酶(phosphatidylcholine2-acylhydrolase),磷脂酰胆碱1-酰基水解酶(phosphatidylcholine1-acylhydrolase),聚(1,4-α-D-半乳糖醛酸苷)半乳糖醛酸水解酶(poly(1,4-alpha-D-galacturonide),聚(1,4-(N-乙酰-β-D-氨基葡糖苷))-聚糖水解酶poly(1,4-(N-acetyl-beta-D-glucosaminide))-glycanohydrolase),蔗糖α-葡糖苷酶(sucrosealpha-glucosidase),三酰基甘油酰基水解酶(triacylglycerolacylhydrolase),和三酰基甘油蛋白酰基水解酶(triacylglycerolprotein-acylhydrolase)。
蛋白水解酶(proteolyticenzyme)
所述其它酶可以是任何在实际过程条件下具有蛋白水解活性的酶。因此,所述酶可以是植物来源的蛋白水解酶,例如木瓜蛋白酶,菠萝蛋白酶,无花果蛋白酶,或动物来源的蛋白水解酶,例如胰蛋白酶和胰凝乳蛋白酶,或微生物来源,即细菌、酵母或丝状真菌来源的蛋白水解酶。应当理解,多种蛋白水解酶中的任何混合物都可适用于本发明的过程。
在另一个优选的实施方式中,所述其它酶是蛋白水解酶,例如丝氨酸蛋白酶、金属蛋白酶或天冬氨酸蛋白酶。
丝氨酸蛋白酶的一个亚类通常被称为枯草蛋白酶(subtilisins)。枯草蛋白酶是革兰氏阳性细菌或真菌产生的丝氨酸蛋白酶。已经测定了多种枯草蛋白酶的氨基酸序列,包括至少6种来自芽孢杆菌属菌株的枯草蛋白酶,即:枯草蛋白酶168,枯草蛋白酶BPN,枯草蛋白酶Carlsberg,枯草蛋白酶DY,枯草蛋白酶amylosacchariticus,和mesentericopeptidase,一种来自放线菌目(actinomycetales)的枯草蛋白酶,来自普通高温放线菌(Thermoactinomycesvulgaris)的thermitase,和一种真菌枯草蛋白酶,来自Tritirachiumalbum的蛋白酶K。Subtilases是更新近被承认的枯草蛋白酶的另一亚类。Subtilases被描述为高度碱性的枯草蛋白酶,包括例如枯草蛋白酶PB92(Gist-BrocadesNV),枯草蛋白酶309(NovozymesA/S),和枯草蛋白酶147(NovozymesA/S)。
“枯草蛋白酶变体或突变的枯草蛋白酶蛋白酶”在本文中定义为由表达来自亲本微生物的突变基因的生物体产生的枯草蛋白酶,所述亲本微生物具有原基因或称亲本基因并产生相应的亲本酶,所述亲本基因已经被突变以产生突变基因,该突变基因在合适的宿主中表达时,产生所述突变的枯草蛋白酶蛋白酶。这些被提到的枯草蛋白酶和其变体构成在本发明的方法中有用的优选蛋白酶类群。有用的枯草蛋白酶变体的例子有枯草蛋白酶309变体其中在195位上甘氨酸被取代为苯丙氨酸(G195F或195Gly到195Phe)。
本发明的方法中可使用可商购的蛋白酶。这样的商品化蛋白酶的例子有(地衣芽孢杆菌菌株深层发酵生产的),(芽孢杆菌属的嗜碱性菌种深层发酵生产的),(Mucormiehei的非病原性菌株深层发酵生产的),(遗传修饰的芽孢杆菌属菌株深层发酵生产的),例如在公开的国际专利申请WO92/19729中披露的变体,以及(的蛋白质工程变体),POLARZYMETM,和EVERLASETM。上述所有的商品化蛋白酶都可以从NovozymesA/S,DK-2880Bagsvaerd,丹麦获得。
其它优选的丝氨酸蛋白酶有来自曲霉属(Aspergillus)、芽孢杆菌属例如嗜碱芽孢杆菌(Bacillusalcalophilus)、蜡状芽孢杆菌(Bacilluscereus)、Bacillusvulgatus、蕈状芽孢杆菌(Bacillusmycoide)和根霉属(Rhizopus)的蛋白酶,和来自芽孢杆菌属的枯草蛋白酶,特别是来自拟诺卡氏菌属(Nocardiopsis)菌种,例如Nocardiopsisnatto和达松维尔拟诺卡氏菌(Nocardiopsisdassonvillei)(参见WO88/03947),特别是来自拟诺卡氏菌属菌种NRRL18262和达松维尔拟诺卡氏菌NRRL18133的蛋白酶。其它优选的蛋白酶有来自国际专利申请PCT/DK89/00002和WO91/00345中公开的芽孢杆菌属枯草蛋白酶的突变体的丝氨酸蛋白酶,和EP415296中公开的蛋白酶。
另一类优选的蛋白酶是微生物来源的金属蛋白酶。本发明中可以使用常规的发酵的商品化金属蛋白酶,例如(Zn)(由枯草芽孢杆菌(Bacillussubtilis)的菌株深层发酵生产),可获自NovozymesA/S,DK-2880Bagsvaerd,丹麦;WO和SI,可获自SandozAG,Basle,瑞士;可获自ToyoBosekiCo.Ltd.,日本;及(由芽孢杆菌属菌种KSM-K16的菌株深层发酵生产),可获自KaoCorporationLtd.,日本。
该蛋白酶可以0.005到500mg酶蛋白每升生物膜控制溶液,优选0.01到100mg酶蛋白每升生物膜控制溶液的剂量使用。
脂肪酶
在另一优选的实施方案中,所述其它酶是脂肪酶,特别是微生物脂肪酶。就此而言,所述脂肪酶可选自酵母,例如假丝酵母;细菌,例如假单胞菌或芽孢杆菌;或丝状真菌,例如腐质霉属(Humicola)或根毛霉属(Rhizomucor)。更具体地,合适的脂肪酶可以是Rhizomucormiehei脂肪酶(例如,如EP238023描述地制备的),Thermomyceslanuginosa脂肪酶,例如按EP305216的描述制备的,特异腐质霉脂肪酶,施氏假单胞菌(Pseudomonasstutzeri)脂肪酶,洋葱假单胞菌(Pseudomonascepacia)脂肪酶、Candidaantarctica脂肪酶A或B,或来自rGPL,Absidiablakesleena,伞枝犁头霉(Absidiacorymbifera),茄病镰孢(Fusariumsolani),尖孢镰孢(Fusariumoxysporum),圆弧青霉(Penicillumcyclopium),皮落青霉(Penicillumcrustosum),扩展青霉(Penicillumexpansum),Rhodotorulaglutinis,Thiarosporellaphaseolina,小孢根霉(Rhizopusmicrosporus),Sporobolomycesshibatanus,出芽短柄霉(Aureobasidiumpullulans),异常汉逊氏酵母(Hansenulaanomala),Geotricumpenicillatum,弯曲乳杆菌(Lactobacilluscurvatus),热杀索丝菌(Brochothrixthermosohata),Coprinuscinerius,Trichodermaharzanium,Trichodermareesei,日本根霉(Rhizopusjaponicus),或植物假单胞菌(Pseudomonasplantari)的脂肪酶。其它合适的脂肪酶的例子可以是上面提到的任何一种脂肪酶的变体,例如WO92/05249或WO93/11254中描述的。
可商购的脂肪酶的例子包括:LIPOLASETM,LIPOLASEULTRATM,LIPOPRIMETM,和LIPEXTM,来自Novozymes,丹麦。
所述脂肪酶可以使用的剂量为0.005到500mg酶蛋白每升生物膜控制溶液,优选0.01-100mg酶蛋白每升生物膜控制溶液。
纤维素酶
在另一个优选的实施方案中,所述其它酶是纤维素酶(cellulase)或纤维素水解酶(cellulolyticenzyme),其指催化纤维素降解为葡萄糖、纤维二糖、三糖和其它纤维寡糖(cellooligosaccharides)的酶。优选地,所述纤维素酶是内切葡聚糖酶(endoglucanase),更优选微生物内切葡聚糖酶,特别是细菌或真菌内切葡聚糖酶。细菌内切葡聚糖酶的例子有从选自假单胞菌属的细菌或灿烂芽孢杆菌(Bacilluslautus)得到的或可由其产生的内切葡聚糖酶。
纤维素酶或内切葡聚糖酶可以是酸性、中性或碱性的纤维素酶或内切葡聚糖酶,即,分别在酸性、中性或碱性的pH范围表现最大的纤维素水解活性。因此,有用的纤维素酶或内切葡聚糖酶是酸性纤维素酶或内切葡聚糖酶,优选真菌酸性纤维素酶或内切葡聚糖酶,更优选在酸性条件下具有显著的纤维素水解活性的真菌酸性纤维素酶或内切葡聚糖酶,其中所述酶是从选自木霉属(Trichoderma)、放线菌属(Actinomyces)、漆斑菌属(Myrothecium)、曲霉属和葡萄孢属(Botrytis)的真菌得到或可由其产生的。
优选的酸性纤维素酶或内切葡聚糖酶是从由黑曲霉(Aspergillusniger),米曲霉(Aspergillusoryzae)、灰色葡萄孢(Botrytiscinerea),疣孢漆斑菌(Myrotheciumverrucaria),长枝木霉(Trichodermalongibrachiatum),里氏木霉(Trichodermareesei),和绿色木霉(Trichodermaviride)构成的组得到的。
另一种有用的纤维素酶或内切葡聚糖酶是中性或碱性纤维素酶或内切葡聚糖酶,优选真菌中性或碱性纤维素酶或内切葡聚糖酶,更优选在中性或碱性条件下具有显著的纤维素水解活性的真菌中性或碱性纤维素酶或内切葡聚糖酶,其中所述酶从选自支顶孢属(Acremonium)、曲霉属、毛壳霉属(Chaetomium)、头孢属(Cephalosporium)、镰孢属(Fusarium)、胶霉属(Gliocladium)、腐质霉属、耙菌属(Irpex)、毁丝霉属(Myceliophthora)、疣孢霉属(Mycogone),漆斑菌属,丝葚霉属(Papulospora),青霉属(Penicillium),帚霉属(Scopulariopsis),葡萄穗霉属(Stachybotrys),和轮枝孢属(Verticillium)的真菌获得或可由其产生。
优选的碱性纤维素酶或葡聚糖酶是从头孢属的菌种、尖孢镰孢,特异腐质霉,或Myceliopthorathermophila,或优选从头孢属菌种RYM-202,Fusariumoxysporum,DSM2672,特异腐质霉,DSM1800,或Myceliopthorathermophila,CBS117.65获得的。
在另一个优选的实施方案中,所述其它酶是木聚糖酶,例如内切1,3-β-木糖苷酶(endo-1,3-β-xylosidase)(EC3.2.1.32),木聚糖1,4-β-木糖苷酶(xylan1,4-β-xylosidase)(EC3.2.1.37),和α-L-阿拉伯呋喃糖苷酶(α-L-arabinofuranosidase)(EC3.2.1.55)。优选地,所述木聚糖酶选自Aspergillusaculeatus(一种表现木聚糖酶活性的酶,该酶与针对来自AspergillusaculeatusCBS101.43的纯化的木聚糖酶的抗体有免疫反应性,参见例如WO94/21785);米曲霉(参见例如SU4610007);出芽短柄霉(参见例如EP0373107A2);环状芽孢杆菌(Bacilluscirculans)(WO91/18978);短小芽孢杆菌(Bacilluspumilus)(参见例如WO92/03540);嗜热脂肪芽孢杆菌(Bacillusstearothermophilus)(参见例如WO91/18976,WO91/10724);芽孢杆菌属菌种AC13(特别是NCIMB40482菌株,参见例如WO94/01532);特异腐质霉(参见例如WO92/17573);红嗜热盐菌属(Rhodothermus)(参见例如WO93/08275);浅青紫链霉菌(Streptomyceslividans)(参见例如WO93/03155);绿孢链霉菌(Streptomycesviridosporus)(参见例如EP496671A);地衣芽孢杆菌(参见例如JP9213868);橙色热子囊菌(Thermoascusaurantiacus)(参见例如美国专利4,966,850);Trichodermalongibrachiatum和Chainia属的菌种(参见例如EP0353342A1);TrichodermaharzianumandTrichodermareseei(参见例如美国专利4,725,544);Thermomyceslanuginosus(参见例如EP0456033A2);褐色热单胞(Thermomonosporafusca)(参见例如EP0473545A2);Trichodermalongibrachiatum(参见W.J.J.vandenTweel等编,StabilityofEnzymes,ProceedingsofanInternationalSymposiumheldinMaastrich,TheNetherlands,1992.11.22-25,Fisk,R.S.和Simpson,pp.323-328);网球菌属(Dictyoglomus)(参见例如WO92/18612);链霉菌属(Streptomyces)(参见例如美国专利5,116,746);和/或栖热袍菌属(Thermotoga)(参见例如WO93/19171)。其它合适的木聚糖酶的例子有上述任一种酶具有木聚糖水解活性的变体(衍生物或同源物)。
可商购的含纤维素酶产品的例子包括:NOVOZYMTM342,CELLUZYMETM,CAREZYMETM,RENOZYMETM(都来自Novozymes,丹麦)。
该纤维素酶可以0.005到500mg酶蛋白每升生物膜控制溶液,优选0.01到100mg酶蛋白每升生物膜控制溶液的剂量使用。
果胶酶
在另一优选的实施方案中,所述其它的酶是果胶酶,例如多聚半乳糖醛酸酶(polygalacturonase)(EC3.2.1.15)、果胶酯酶(pectinesterase)(EC3.2.1.11),或胶质裂合酶(pectinlyase)(EC4.2.2.10)。果胶酶的合适的来源生物可以是黑曲霉。
在另一个优选的实施方案中,所述α-淀粉酶组合物中的其它酶包括由真菌棘孢曲霉(Aspergillusaculeatus),优选棘孢曲霉,CBS101.43所产生的水解性酶的组合物。已知该菌株产生包含果胶分解(pectinolytic)和多种半纤维素分解(hemicellulolytic)酶活性。
可商购的含果胶酶的产品的例子包括:BioPrepTM,SCOURZYMETM和PECTAWASHTM(Novozymes,丹麦)。
该果胶酶可以0.005到500mg酶蛋白每升生物膜控制溶液,优选0.01到100mg酶蛋白每升生物膜控制溶液的剂量使用。
氧化还原酶
在本发明的另一实施方案中,所述α-淀粉酶与氧化还原酶,例如氧化酶、过氧化物酶或漆酶组合。
a)漆酶作用于分子氧,产生水(H2O),而不需任何过氧化物(例如H2O2),
b)氧化酶作用于分子氧,产生过氧化物(H2O2),
c)过氧化物酶作用于过氧化物(例如H2O2),产生水(H2O)。
漆酶(E.C.1.10.3.2)的例子包括来自多孔菌属(Polyporus)菌种的菌株,特别是Polyporuspinsitus或变色多孔菌(Polyporusversicolor)的菌株,或毁丝霉属菌种的菌株,特别是M.thermophila,Scytalidium属菌种的菌株,特别是S.thermophilium,丝核菌(Rhizoctonia)属菌种的菌株,特别是Rhizoctoniapraticola或茄属丝核菌(Rhizoctoniasolani),或Rhus属菌种的菌株,特别是Rhusvernicifera。所述漆酶还可以来自真菌例如金钱菌属(Collybia),层孔菌属(Fomes),香菇属(Lentinus),灰侧耳菌属(Pleurotus),曲霉属,脉孢霉属(Neurospora),Podospora属,射脉菌属(Phlebia),例如辐射射脉菌(P.radiata)(WO92/01046),革盖菌属(Coriolus)的菌种,例如毛革盖菌(C.hirsitus)(JP2-238885),或葡萄孢属。
在具体考虑的实施方案中,所述漆酶可以选自WO96/00290中描述的Polyporuspinisitus漆酶(也称为Trametesvillosa漆酶),WO95/33836中描述的Myceliophthorathermophila漆酶,WO95/33837中描述的Scytalidiumthermophilium漆酶,可从SIGMA购买的商品名为SIGMAno.L5510的Pyriculariaoryzae漆酶,WO96/06930中描述的Coprinuscinereus漆酶,及WO95/07988中描述的茄属丝核菌漆酶。
过氧化物酶(1.11.1.7)的例子包括来自植物的过氧化物酶(例如辣根过氧化物酶)或来自微生物的过氧化物酶,包括真菌和细菌,例如Coprinus属菌种,诸如Coprinuscinereus或Coprinusmacrorhizus的菌株,或细菌,例如芽孢杆菌属,诸如短小芽孢杆菌。
在特别考虑的实施方案中,所述过氧化物酶可选自:WO95/10602中公开的CoprinuscinereusIFO8371过氧化物酶或其变体,以及来源于WO97/04102中描述的CurvulariaverruculosaCBS147.63菌株的卤素过氧化物酶(haloperoxidase)。
考虑到的氧化酶特别包括糖氧化酶(carbohydrateoxidases),这些酶被归类为EC1.1.3。糖氧化酶包括葡萄糖氧化酶(E.C.1.1.3.4),己糖氧化酶(E.C.1.1.3.5),木糖醇氧化酶,半乳糖氧化酶(E.C.1.1.3.9),吡喃糖氧化酶(E.C.1.1.3.10),醇氧化酶(E.C.1.1.3.13)。
糖氧化酶可来自任何来源,包括细菌、真菌、酵母或哺乳动物来源。
葡萄糖氧化酶的例子包括来自曲霉属的菌种,例如黑曲霉的菌株,或来自Cladosporium属的菌种,尤其是Cladosporiumoxysporum,特别是WO95/29996中描述的Cl.oxysporumCBS163的葡萄糖氧化酶。
己糖氧化酶的例子包括由红色海藻Chondruscrispus(通常称为角叉菜(Irishmoss)产生的己糖氧化酶(Sullivan和Ikawa,(1973),Biochim.Biophys.Acts,309,p.11-22;Ikawa,(1982),Meth.inEnzymol.89,carbohydratemetabolismpartD,145-149),其氧化广谱的糖类,以及产生容易提取的己糖氧化酶的红色海藻Iridophycusflaccidum所产生的己糖氧化酶,其氧化数种不同的单糖和双糖(Bean和Hassid,(1956),J.Biol.Chem,218,p.425;Rand等,(1972),J.ofFoodScience37,p.698-710)。
该氧化还原酶可以0.005到500mg酶蛋白每升生物膜控制溶液,优选0.01到100mg酶蛋白每升生物膜控制溶液的剂量使用。
本发明的最后一方面涉及使用芽孢杆菌α-淀粉酶来防止、去除、减少或破坏表面上的生物膜生成物。在一个优选的实施方案中,所述α-淀粉酶是芽孢杆菌α-淀粉酶,优选上面的“α-淀粉酶”部分提到的α-淀粉酶。
下面的实施例对本发明进行进一步的说明,它们不应被理解为对本发明范围的限制。
材料和方法
作为缓冲剂和试剂使用的化学品都是商品化的产品,至少为试剂级。
酶:
α-淀粉酶-A是作为亲本的WO00/60060的SEQIDNO:2所描述的芽孢杆菌属菌种的α-淀粉酶的变体。所述α-淀粉酶的氨基酸序列具有下面6个氨基酸缺失/取代:
D183*+G184*+R118K+N195F+R320K+R458K。
该变体在WO01/66712也有公开。该碱性α-淀粉酶以批号03AGE014-4生产。
α-淀粉酶B来自黄热芽孢杆菌菌株,并在SEQIDNO:4中公开。
α-淀粉酶C来自地衣芽孢杆菌菌株,并在WO99/19467的SEQIDNO:6中显示。
蛋白酶E是克劳氏芽孢杆菌(Bacillusclausii)(旧名:迟缓芽孢杆菌(Bacilluslentus)C360=NCIB10309)的一种枯草蛋白酶,具有取代M222S,并被EP专利396,608-B1所覆盖(可从Novozymes,丹麦索取)。
脂肪酶A是源自疏棉状腐质霉(Humicolalanuginosa)菌株DSM4109的脂肪酶变体,其具有下列突变:T231R,N233R,公开于美国专利6,939,702-B(可从Novozymes索取)。
纤维素酶A是来自特异腐质霉的多组分纤维素酶(可从Novozymes索取)。
细菌菌株
得自ATCC10774的枯草芽孢杆菌
大肠杆菌ATCC#11229和ATCC#25922
生物膜培养基根据供应商的指导制备胰胨豆胨肉汤(TrypticSoyBroth,TSB,购自VWR,P/NDF0370-07)培养基,再用水稀释到5%。每升加入2ml微量元素。
琼脂根据供应商的指导使用胰胨豆胨琼脂(TrypticSoyAgar,TSA,购自VWR,P/NDF0369-17)。
微量元素溶液每升:1.5gCaCl2,1.0gFeSO4·7H2O,0.35gMnSO4.2H2O,0.5gNaMoO4
不锈钢试片(coupons)不锈钢试片No.304自MetalSamplesCompany(Munford,AL)获得。
BioLC离子色谱系统该IC系统由下列组件构成:
GP50梯度泵(P/N059493)
ED50A电化学检测器(P/N059499)
AS50温控自动进样器(P/N056565)
用于积分电流检测(IntegratedAmperometry)的电化学检测池(ElectrochemicalCell),备全了金电极和Ag/AgCl参比电极(P/N060386)
Chromelion数据控制软件CHM-1-IC(P/N060930)
CDC生物膜反应器:购自BiosurfaceTechnologies,Inc.(P/NCBR90-2),备全了聚碳酸盐试片(每个反应器24个,P/NRD128-PC)。
去污剂清洁基料(DetergentCleanerBase),得自WeimanProducts(IL,美国),品名为BurnishineME-多酶去污剂。在使用前通过微波炉高档位(highsetting)加热1分钟来使酶变性。
方法:
α-淀粉酶活性(KNU)
可使用马铃薯淀粉作为底物测定淀粉水解活性。该方法基于酶降解变性的(modified)马铃薯淀粉,通过将淀粉/酶溶液的样品与碘溶液混合来追踪该反应。开始,生成蓝黑色,但在淀粉降解的过程中蓝色变弱,并逐渐变成红棕色,将其与有色玻璃标准比较。
1千Novoα-淀粉酶单位(KNU)定义为在标准条件下(即37°C+/-0.05;0.0003MCa2+;pH5.6)糊精化(dextrinize)5260mg的MerckAmylumsolubile淀粉干物质的酶量。
更详细地描述这种分析方法的小册子EB-SM-0009.02/01可从NovozymesA/S,丹麦索取,在此将该小册子并入本文作为参考。
两个序列之间的同一性程度的确定
为了本发明的目的,可以通过Clustal方法(Higgins,1989,CABIOS5:151-153)确定两个氨基酸序列间的同一性程度,其中上述方法使用的是LASERGENETMMEGALIGNTM软件(DNASTAR,Inc.,Madison,WI),该软件带有同一性列表以及以下多个比对参数:空位罚分(gappenalty)10,空位长度罚分(gaplengthpenalty)10。配对比对参数如下:Ktuple=1,空位罚分=3,windows=5,diagonals=5。
实施例
实施例1
使用α-淀粉酶A和α-淀粉酶C去除生物膜
生物膜反应器由400ml烧杯、磁力搅拌器和2个不锈钢试片(coupon)组成。将试片垂直地用胶带固定(taped)在烧杯的壁上,并使试片的底边落在烧杯的底上。加入搅拌子,用圆形铝箔覆盖烧杯并高压蒸汽灭菌。向每个烧杯中加入200ml无菌的生物膜培养基。为了培养接种物,将每种细菌菌株(来自枯草芽孢杆菌)在平板计数琼脂(platecountagar)上28℃培养过夜。用无菌的拭子将每种菌株悬浮在无菌水中至OD686为0.100,然后进一步稀释至10-1。每个测试由4个没有酶的对照烧杯、2个具有50mg酶蛋白每升溶液的烧杯,和2个具有100mg酶蛋白每升溶液的烧杯组成。首先在37℃搅拌下将烧杯温育过夜以在不锈钢试片上生长生物膜。该温育步骤后,以上述的2种剂量按照下表加入酶,在40℃下再温育2小时。然后,用无菌水小心地洗涤每个烧杯和不锈钢试片,用结晶紫染色,用无菌水清洗,用乙酸溶解残余的生物膜,然后用分光光度计在600nm下测量等份的每种溶液的吸光度。所测得的这些溶液的吸光度直接地指示不锈钢试片上残余的生物膜的量。低的吸光度对应于酶的效用良好,几乎没有生物膜残余;高的吸光度对应于酶的效用差(或没有),有显著的生物膜残余。
样品# | 所用的酶 | 酶蛋白浓度 |
1 | α-淀粉酶A | 50mg每L和100mg每L |
2 | α-淀粉酶C | 50mg每L&100mg每L |
3 | 无酶(对照) | NA |
实施例2
使用α-淀粉酶A、B和C溶解粗淀粉
测量不同的α-淀粉酶溶解粗的(raw)、非水化的(unhydrated)小麦淀粉的速率。该研究中分别使用α-淀粉酶A、B和C。
将具有pH8Tris缓冲液、15°dH的1%粗小麦淀粉溶液25毫升倒入带盖的管中,放在40℃水浴中。在加入酶之前,测量“还原端”(reducingends)的初始水平。该研究中所用的酶浓度为3mg酶蛋白每g粗小麦淀粉。在不同的时间取出1ml的样品。加入20微升的1MHCl,然后在99℃温育10分钟。酸和热的联合作用使淀粉酶失活。加入20μL的1MNaOH以确保样品不再为酸性。然后将样品稀释,与显色试剂(colorreagent)(PHABH,酒石酸钠钾盐,NaOH)在95℃下共同温育10分钟,最后离心,再测量上清在410nm处的OD。将1MHCl中的粗小麦淀粉的1%溶液在110℃的烘箱中温育4小时来制备对照(100%水解的淀粉)。使用该处理来计算每克粗小麦淀粉所能够产生的最大量的葡萄糖。该值在图1所示图表中设为100%。
对α-淀粉酶A和B而言,可见在最初的5小时中观察到的粗小麦淀粉溶解初始速率显著地快于α-淀粉酶C。因此,在整个这段时间中,被前两种α-淀粉酶溶解的淀粉的百分率高于后一种酶。
实施例3
使用α-淀粉酶A和C与蛋白酶E和去污剂组合的生物膜去除
在预先灭菌的CDC生物膜反应器中,在聚碳酸酯试片上生长大肠杆菌(ATCC#11229)的单组分生物膜。在实验的开始,在胰胨豆胨琼脂(TSA)上37℃过夜生长大肠杆菌培养物。次日早晨,用1微升无菌接种环从平板上挑取单菌落,加到40gTSB每升水的溶液中。将该溶液在37℃培养过夜,使培养物长起。第二天,将1毫升的该培养物加到CDC生物膜反应器中所含的400ml的基础培养基(0.30gTSB每升无菌水)中。以130rpm缓慢地搅拌该溶液,并以非补料分批模式在22℃下生长2天。2天的生长期后,将试片固定杆(holderrods)和试片从反应器移出,在无菌的稀释水中洗去浮游的细胞,从杆上小心地移下试片,并在40℃下,在下列溶液中(每种30毫升)温育1小时:
A:单独的去污剂清洁基料,0.21g去污剂,于无菌水中。
B:去污剂清洁基料,0.21g+0.51mg酶蛋白的蛋白酶E+0.06mg酶蛋白的α-淀粉酶A。
C:去污剂清洁基料,0.21g+0.51mg酶蛋白的蛋白酶E+0.16mg酶蛋白的α-淀粉酶C。
在温育步骤后,移去试片。将溶液通过0.45μm尼龙注射器式滤器过滤,并用离子色谱分析其糖含量。并使用PA100保护柱(guard)和分析柱(P/N043055)来分离。用60/40去离子水/100mMNaOH与100%100mMNaOH/1M乙酸钠之间的流动相梯度(指数梯度从进入分离后10分钟开始到85分钟为止)来实现分离。图2显示本实验的3个色谱图的重叠。当使用α-淀粉酶A时,相对于单独的去污剂或使用α-淀粉酶C,生成了显著更高水平的低分子量糖类(葡萄糖=glu,麦芽糖=mal,麦芽三糖=DP3,麦芽四糖=DP4,麦芽五糖=DP5)。这显示通过对大肠杆菌细菌产生的支链淀粉外泌多糖(exopolysaccharides)的降解的增加,生物膜去除的水平增加。
实施例4
使用α-淀粉酶A和C与蛋白酶E、纤维素酶A、脂肪酶A和去污剂组
合的生物膜去除
将两个装有聚碳酸酯试片的CDC生物膜反应器高压灭菌,注入无菌的1/10浓度的胰胨豆胨肉汤(TSB,3g/l的浓度),并接种1ml大肠杆菌(ATCC#25922)的对数期培养物。反应器中的起始细胞计数平均为5×108cfu/mL。将两个反应器都以分批模式在37℃下运行24小时(没有流入或流出)。这段时间以后,开始以12ml/min的流速、37℃连续流加1/10TSB。将大肠杆菌生物膜生长4天。此时,从每个反应器(标为反应器1或2)拉出一个杆,放在含有200毫升下列经过过滤除菌的溶液的烧杯中:
A:单独的去污剂清洁基料,1.4g去污剂,于无菌水中。
B:去污剂清洁基料,1.4g+3.4mg酶蛋白的蛋白酶E+0.48mg酶蛋白的脂肪酶A+0.23mg酶蛋白的纤维素酶A+0.40mg酶蛋白的α-淀粉酶A。
C:去污剂清洁基料,1.4g+3.4mg酶蛋白的蛋白酶E+0.48mg酶蛋白的脂肪酶A+0.23mg酶蛋白的纤维素酶A+0.40mg酶蛋白的α-淀粉酶C。
每个烧杯中的溶液在温和搅拌下40℃温育30分钟,然后用无菌水轻柔地清洗每个杆。最后,用胰胨豆胨琼脂(TSA)对每个杆的3个试片中的2个上的大肠杆菌计数。该研究得到的平均平板计数结果如下:
处理 | 试片上的平均log10cfu/cm2 |
A | 4x107 |
B | 3x104 |
C | 2x105 |
本文所描述并要求保护的发明并不限于本文所公开的具体实施方案,因为这些实施方案意在作为本发明的一些方面来说明。意图将任何等价的实施方案都将包括本发明的范围中。事实上,除了本文中示出并描述的那些以外,本领域的技术人员从前面的描述将显而易见地想到多种对本发明的修改。所附的权利要求也意在将这些修改包括在其范围之内。在冲突的情况下,将以包括定义的本公开为准。
本文引用了多种文献,在此将它们全部的公开并入本文作为参考。
Claims (30)
1.一种去除、减少或破坏表面上存在的生物膜的方法,包括使表面与具有SEQIDNO:4所示序列的α-淀粉酶或与SEQIDNO:4具有至少99%同一性的α-淀粉酶接触;且所述α-淀粉酶来源于黄热芽孢杆菌(Bacillusflavothermus)。
2.权利要求1的方法,其中使被生物膜污染或易于产生生物膜的表面接触1分钟到2天。
3.权利要求1或2的方法,其中与所述α-淀粉酶同时与表面接触的还有表面活性剂。
4.权利要求1的方法,其中所述α-淀粉酶在其N末端氨基酸区域中包含Asn-Gly-Thr-Met-Met-Gln-Tyr-Phe-Glu-Trp。
5.权利要求1或2的方法,其中所述α-淀粉酶以0.005-500mg酶蛋白每升生物膜控制溶液的浓度使用。
6.权利要求5的方法,其中所述α-淀粉酶以0.01–100mg酶蛋白每升生物膜控制溶液的浓度使用。
7.权利要求1的方法,其中所述α-淀粉酶在40℃、3mg酶蛋白每g淀粉、pH8.0下5小时后,具有高于15的水解淀粉百分率(%)。
8.权利要求7的方法,其中所述α-淀粉酶在40℃、3mg酶蛋白每g淀粉、pH8.0下5小时后,具有高于25的水解淀粉百分率(%)。
9.权利要求7的方法,其中所述α-淀粉酶在40℃、3mg酶蛋白每g淀粉、pH8.0下5小时后,具有高于35的水解淀粉百分率(%)。
10.权利要求1的方法,其中与所述α-淀粉酶同时与表面接触的还存在其它的酶,这些酶选自:淀粉酶、糖酶、过氧化氢酶、纤维素酶、几丁质酶、环糊精糖基转移酶、酯酶、α-半乳糖苷酶、β-半乳糖苷酶、葡糖淀粉酶、α-葡萄糖苷酶、β-葡萄糖苷酶、卤素过氧化物酶、转化酶、漆酶、甘露糖苷酶、氧化还原酶、果胶分解酶、肽谷氨酰胺酶、过氧化物酶、肌醇六磷酸酶、多酚氧化酶、蛋白水解酶、转谷氨酰胺酶或木聚糖酶。
11.权利要求10的方法,其中所述蛋白水解酶是氨肽酶或羧肽酶。
12.权利要求10的方法,其中所述酯酶是脱氧核糖核酸酶、核糖核酸酶、角质酶或脂肪酶。
13.权利要求10的方法,其中所述果胶分解酶选自果胶反式消除酶(pectintranseliminase)、多聚半乳糖醛酸酶、果胶酯酶。
14.权利要求10的方法,其中所述纤维素酶是多组分纤维素酶制剂或内切葡聚糖酶。
15.权利要求10的方法,其中所述纤维素酶是腐质霉属内切葡聚糖酶。
16.权利要求10的方法,其中所述纤维素酶是Humicolainsolens内切葡聚糖酶。
17.权利要求13的方法,其中所述纤维素酶是来自特异腐质霉DSM1800的EGI或EGV内切葡聚糖酶或其变体。
18.权利要求10的方法,其中所述纤维素酶是Thielavia属内切葡聚糖酶或其变体。
19.权利要求10的方法,其中所述纤维素酶是Thielaviaterrestris内切葡聚糖酶,或其变体。
20.权利要求10的方法,其中所述蛋白水解酶是丝氨酸蛋白酶或其变体。
21.权利要求10的方法,其中所述蛋白水解酶源自芽孢杆菌属菌株。
22.权利要求10的方法,其中所述蛋白水解酶源自迟缓芽孢杆菌或Bacillusclausii。
23.权利要求1-2中任一项的方法,其中与所述α-淀粉酶同时与表面接触的还存在选自分散剂、表面活性剂和杀生物剂的一种或多种试剂。
24.权利要求23的方法,其中所述杀生物剂是抗微生物剂。
25.权利要求1-2中任一项的方法,其中所述表面是硬、软或多孔表面。
26.权利要求25的方法,其中所述表面是膜(membrane)。
27.权利要求1-2中任一项的方法,其中所述生物膜的去除是在10-70℃的温度下进行的。
28.权利要求27的方法,其中所述生物膜的去除是在40-60℃的温度下进行的。
29.权利要求1-28任一项所定义的α-淀粉酶在去除表面的生物膜中的用途。
30.权利要求29的用途,其中使用权利要求10-28任一项中定义的其它酶和/或试剂与所述α-淀粉酶同时与表面接触。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60853504P | 2004-09-10 | 2004-09-10 | |
US60/608,535 | 2004-09-10 | ||
CNA2005800300950A CN101040052A (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2005800300950A Division CN101040052A (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103182387A CN103182387A (zh) | 2013-07-03 |
CN103182387B true CN103182387B (zh) | 2016-01-06 |
Family
ID=36060538
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210357075.6A Active CN103182387B (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
CN201210357051.0A Active CN103181400B (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
CNA2005800300950A Pending CN101040052A (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
CN201210356472.1A Active CN102919273B (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210357051.0A Active CN103181400B (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
CNA2005800300950A Pending CN101040052A (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
CN201210356472.1A Active CN102919273B (zh) | 2004-09-10 | 2005-09-07 | 防止、去除、减少或破坏生物膜的方法 |
Country Status (6)
Country | Link |
---|---|
US (4) | US20080248558A1 (zh) |
EP (3) | EP2258836B1 (zh) |
JP (1) | JP5345781B2 (zh) |
CN (4) | CN103182387B (zh) |
DK (1) | DK2258836T3 (zh) |
WO (1) | WO2006031554A2 (zh) |
Families Citing this family (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
CN100406567C (zh) * | 2002-01-22 | 2008-07-30 | 生物材料公司 | 生物可降解聚合物的干燥方法 |
US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
US7993675B2 (en) * | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
US20080019956A1 (en) * | 2006-07-24 | 2008-01-24 | Manoj Kumar | Enzymatic prevention and control of biofilm |
EP2094317B1 (en) * | 2006-11-08 | 2010-09-15 | B-K Medical ApS | Method for multi-step sterilization |
KR20150041172A (ko) * | 2006-12-01 | 2015-04-15 | 래크리드 인코포레이티드 | 귀에서 균막을 용해시키기 위한 가수분해 및 산화 효소의 용도 |
US8343536B2 (en) | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
EP2712614B1 (en) * | 2007-02-08 | 2017-11-29 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use |
US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
EP2126089A2 (en) * | 2007-03-09 | 2009-12-02 | Danisco US, INC., Genencor Division | Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use |
DK2500325T3 (da) | 2007-03-23 | 2014-10-06 | Novozymes Biologicals Inc | Forebyggelse og reducering af biofilmdannelse og planktonformering |
WO2008153815A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Variants of an alpha-amylase with improved production levels in fermentation processes |
NZ584434A (en) | 2007-11-05 | 2011-12-22 | Danisco Us Inc | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
AU2008343325B2 (en) | 2007-12-20 | 2013-08-15 | Danisco Us Inc. | Enzymatic prevention and control of biofilm |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
EP2303254B1 (en) | 2008-06-12 | 2019-10-30 | Medtronic Xomed, Inc. | Product for treating chronic wounds with an extracellular polymeric substance solvating system |
US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
WO2010002972A1 (en) | 2008-07-01 | 2010-01-07 | Curemark, Llc | Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
US20100008893A1 (en) * | 2008-07-11 | 2010-01-14 | Novozymes A/S | Bacillus velezensis strain |
US20100028314A1 (en) * | 2008-07-30 | 2010-02-04 | Novozymes A/S | Bacillus Amyloliquefaciens Strain |
US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
US20100086576A1 (en) * | 2008-10-06 | 2010-04-08 | Myntti Matthew F | Antimicrobial composition and methods of making and using same |
CN105664144B (zh) * | 2009-01-06 | 2020-08-11 | 加尔纳根有限责任公司 | 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法 |
AU2015252099B2 (en) * | 2009-01-06 | 2017-08-10 | Galenagen, Llc | Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces |
US9084784B2 (en) | 2009-01-06 | 2015-07-21 | Curelon Llc | Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces |
US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
JP2011020977A (ja) * | 2009-07-19 | 2011-02-03 | Tsutomu Takatani | 蘚苔類及び藍藻類の制御剤及びこれを用いる制御方法 |
WO2011050135A1 (en) | 2009-10-21 | 2011-04-28 | Curemark Llc | Methods and compositions for the prevention and treatment of influenza |
CN102712512A (zh) * | 2009-11-10 | 2012-10-03 | 诺维信生物股份有限公司 | 用于控制膜结垢的方法、组合物和系统 |
CA2780756A1 (en) * | 2009-11-23 | 2011-05-26 | Prothera, Inc. | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
GB2477914B (en) | 2010-02-12 | 2012-01-04 | Univ Newcastle | Compounds and methods for biofilm disruption and prevention |
US9234251B2 (en) | 2010-03-19 | 2016-01-12 | Novozymes Biologicals, Inc. | Bacillus amyloliquefaciens strain |
CN103025856B (zh) * | 2010-07-22 | 2017-04-12 | 荷兰联合利华有限公司 | 包含生物表面活性剂和酶的洗涤剂组合物 |
CN103052703A (zh) * | 2010-07-22 | 2013-04-17 | 荷兰联合利华有限公司 | 包含生物表面活性剂和脂肪酶的洗涤剂组合物 |
WO2012048758A1 (fr) * | 2010-10-15 | 2012-04-19 | S.A. Realco | Produit et procede d'elimination des biofilms |
CA2817105A1 (fr) * | 2010-10-15 | 2012-04-19 | S.A. Realco | Produit et procede d'elimination des biofilms |
JP5856749B2 (ja) * | 2011-04-01 | 2016-02-10 | 旭化成ケミカルズ株式会社 | バイオフィルム除去剤 |
CN103619348B (zh) | 2011-04-21 | 2016-10-26 | 柯尔马克有限责任公司 | 用于治疗神经精神障碍的化合物 |
CA2835211C (en) | 2011-05-10 | 2019-09-24 | Next Science, Llc | Antimicrobial solid and methods of making and using same |
BR112014013897A2 (pt) * | 2011-12-08 | 2018-04-10 | P Suiter Thomas | sistema de manuseamento de mangueira e métodos de utilização |
US10150144B2 (en) | 2011-12-08 | 2018-12-11 | Thomas P. Suiter | Hose handling system and methods of use |
DE102012201522A1 (de) * | 2012-02-02 | 2013-08-08 | Basf Se | Lagerstabiles flüssiges Geschirrspülmittel enthaltend Protease und Amylase |
JP6327496B2 (ja) * | 2012-05-30 | 2018-05-23 | 有限会社カイ | 酵素処理液を使用する抗感染症処理剤 |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
BR112015012982A2 (pt) * | 2012-12-07 | 2017-09-12 | Novozymes As | composição detergente, método de lavagem para têxtil, têxtil lavado, e, uso de uma desoxirribonuclease |
JPWO2014178380A1 (ja) * | 2013-04-30 | 2017-02-23 | 株式会社カネカ | 放射性セシウム汚染水の浄化方法 |
BE1021388B1 (fr) * | 2013-05-22 | 2015-11-13 | Realco | Procede d'aumentation de la duree de vie de denrees perissables. |
JP2016526880A (ja) | 2013-05-29 | 2016-09-08 | ダニスコ・ユーエス・インク | 新規メタロプロテアーゼ |
WO2014194117A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
EP3004314B1 (en) | 2013-05-29 | 2018-06-20 | Danisco US Inc. | Novel metalloproteases |
EP3260538B1 (en) | 2013-05-29 | 2021-04-14 | Danisco US Inc. | Novel metalloproteases |
CN104222158A (zh) * | 2013-06-19 | 2014-12-24 | 深圳市绿微康生物工程有限公司 | 生物菌群去除剂 |
DK3553173T3 (da) | 2013-12-13 | 2021-08-23 | Danisco Us Inc | Serinproteaser af bacillus gibsonii-clade |
DK3514230T3 (da) | 2013-12-13 | 2021-11-15 | Danisco Us Inc | Serinproteaser af bacillus-arter |
AU2014366222B2 (en) | 2013-12-16 | 2018-07-19 | Nutrition & Biosciences USA 4, Inc. | Use of poly alpha-1,3-glucan ethers as viscosity modifiers |
EP3083705B1 (en) | 2013-12-18 | 2020-09-30 | DuPont Industrial Biosciences USA, LLC | Cationic poly alpha-1,3-glucan ethers |
CN105992796A (zh) | 2014-02-14 | 2016-10-05 | 纳幕尔杜邦公司 | 用于粘度调节的聚-α-1,3-1,6-葡聚糖 |
US9695253B2 (en) | 2014-03-11 | 2017-07-04 | E I Du Pont De Nemours And Company | Oxidized poly alpha-1,3-glucan |
WO2015143360A2 (en) | 2014-03-21 | 2015-09-24 | Danisco Us Inc. | Serine proteases of bacillus species |
JP6825911B2 (ja) | 2014-04-11 | 2021-02-03 | ノボザイムス アクティーゼルスカブ | 洗剤組成物 |
ES2843276T3 (es) | 2014-04-25 | 2021-07-16 | Basf Se | Variantes de amilasa |
WO2015166075A1 (en) * | 2014-05-02 | 2015-11-05 | Novozymes A/S | Detergent composition |
EP3158043B1 (en) | 2014-06-19 | 2021-03-10 | Nutrition & Biosciences USA 4, Inc. | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
DE102014009813A1 (de) * | 2014-07-03 | 2016-01-07 | Biopract Gmbh | Verfahren zur Prophylaxe von Pilzinfektionen bei Nutz- und Zierpflanzen, bevorzugt beim Weinbau, sowie bei Gehölzen |
CN104286030A (zh) * | 2014-09-30 | 2015-01-21 | 中国海洋石油总公司 | 一种用于循环冷却水的生物酶生物粘泥抑制剂 |
WO2016061438A1 (en) | 2014-10-17 | 2016-04-21 | Danisco Us Inc. | Serine proteases of bacillus species |
EP3212783B1 (en) | 2014-10-27 | 2024-06-26 | Danisco US Inc. | Serine proteases |
EP3550017B1 (en) | 2014-10-27 | 2021-07-14 | Danisco US Inc. | Serine proteases |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
DK3212781T3 (da) | 2014-10-27 | 2019-12-16 | Danisco Us Inc | Serinproteaser |
EP3212662B1 (en) | 2014-10-27 | 2020-04-08 | Danisco US Inc. | Serine proteases |
WO2016106013A1 (en) | 2014-12-23 | 2016-06-30 | E. I. Du Pont De Nemours And Company | Enzymatically produced cellulose |
WO2016183509A1 (en) | 2015-05-13 | 2016-11-17 | Danisco Us Inc. | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF |
CN104909454B (zh) * | 2015-05-19 | 2017-06-23 | 中国科学院广州能源研究所 | 一种解除厌氧反应器中软性纤维填料生物膜结团的方法 |
WO2016196680A1 (en) * | 2015-06-01 | 2016-12-08 | Robert Caron | Biofilm control and frack fluid production using bacillus subtilis activated with gfak |
WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
WO2016201044A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Osmotic burst encapsulates |
WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
US11499146B2 (en) | 2015-06-17 | 2022-11-15 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
IL258550B (en) * | 2015-10-14 | 2022-06-01 | Novozymes As | Cleaning of water filtration membranes |
WO2017066510A1 (en) * | 2015-10-14 | 2017-04-20 | Novozymes A/S | Cleaning of water filtration membranes |
BR112018009050A8 (pt) | 2015-11-05 | 2019-02-26 | Danisco Us Inc | mananases de paenibacillus e bacillus spp. |
EP4141113A1 (en) | 2015-11-05 | 2023-03-01 | Danisco US Inc | Paenibacillus sp. mannanases |
EP3374401B1 (en) | 2015-11-13 | 2022-04-06 | Nutrition & Biosciences USA 4, Inc. | Glucan fiber compositions for use in laundry care and fabric care |
WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
WO2017083228A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
CN105567667A (zh) * | 2015-11-24 | 2016-05-11 | 威海翔宇环保科技股份有限公司 | 一种控制循环水中生物粘泥的生物酶药剂 |
WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
CN109715791B (zh) | 2016-05-03 | 2023-07-14 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
US20190136218A1 (en) | 2016-05-05 | 2019-05-09 | Danisco Us Inc | Protease variants and uses thereof |
MX2018014768A (es) | 2016-05-31 | 2019-03-06 | Danisco Us Inc | Variantes de proteasa y sus usos. |
EP4151726A1 (en) | 2016-06-17 | 2023-03-22 | Danisco US Inc | Protease variants and uses thereof |
CN106376597A (zh) * | 2016-08-30 | 2017-02-08 | 北京达成生物科技有限公司 | 一种多酶复合抑菌剂 |
EP3519548A1 (en) * | 2016-09-29 | 2019-08-07 | Novozymes A/S | Use of enzyme for washing, method for washing and warewashing composition |
EP3535365A2 (en) | 2016-11-07 | 2019-09-11 | Danisco US Inc. | Laundry detergent composition |
US11946081B2 (en) | 2016-12-21 | 2024-04-02 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
CN106621824B (zh) * | 2017-01-03 | 2019-08-13 | 东北电力大学 | 一种缓解膜生物反应器中生物膜污染的解体剂 |
CN110381973A (zh) * | 2017-03-06 | 2019-10-25 | 诺维信公司 | 一种或多种酶在防止、抑制或减少表面上微生物生长中的用途 |
EP3583210B1 (en) | 2017-03-15 | 2021-07-07 | Danisco US Inc. | Trypsin-like serine proteases and uses thereof |
WO2018183662A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Delayed release enzyme formulations for bleach-containing detergents |
US11149233B2 (en) | 2017-03-31 | 2021-10-19 | Novozymes A/S | Polypeptides having RNase activity |
US11339355B2 (en) | 2017-04-04 | 2022-05-24 | Novozymes A/S | Glycosyl hydrolases |
CA3067837A1 (en) | 2017-06-30 | 2019-01-03 | Danisco Us Inc | Low-agglomeration, enzyme-containing particles |
CN107197877B (zh) * | 2017-07-12 | 2020-04-21 | 宿迁研美生物科技有限公司 | 生物复合酶病毒清除剂(消毒剂) |
CN107991471A (zh) * | 2017-11-24 | 2018-05-04 | 吉林建筑大学 | 一种水-生物膜可见光照模拟实验装置 |
EP3717643A1 (en) | 2017-11-29 | 2020-10-07 | Danisco US Inc. | Subtilisin variants having improved stability |
CA3086202A1 (en) | 2017-12-21 | 2019-06-27 | Danisco Us Inc. | Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant |
CN111867388A (zh) | 2018-02-08 | 2020-10-30 | 丹尼斯科美国公司 | 用于酶包封的耐热蜡基质颗粒 |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
CN109160615A (zh) * | 2018-07-21 | 2019-01-08 | 东南大学 | 一种同步缓解膜生物反应器膜污染与控制污泥产率的方法 |
EP3844255A1 (en) | 2018-08-30 | 2021-07-07 | Danisco US Inc. | Enzyme-containing granules |
CN109133356B (zh) * | 2018-09-12 | 2021-09-14 | 浙江海洋大学 | 一种利用滤食生物除藻的方法 |
WO2020068486A1 (en) | 2018-09-27 | 2020-04-02 | Danisco Us Inc | Compositions for medical instrument cleaning |
EP3861110A1 (en) | 2018-10-02 | 2021-08-11 | Novozymes A/S | Endonuclease 1 ribonucleases for cleaning |
WO2020070014A1 (en) | 2018-10-02 | 2020-04-09 | Novozymes A/S | Cleaning composition comprising anionic surfactant and a polypeptide having rnase activity |
US20230028935A1 (en) | 2018-11-28 | 2023-01-26 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2020242858A1 (en) | 2019-05-24 | 2020-12-03 | Danisco Us Inc | Subtilisin variants and methods of use |
US20220306968A1 (en) | 2019-06-06 | 2022-09-29 | Danisco Us Inc | Methods and compositions for cleaning |
WO2021207679A1 (en) | 2020-04-10 | 2021-10-14 | Liberty Biosecurity, Llc | Polypeptide compositions and uses thereof |
WO2021207687A1 (en) | 2020-04-10 | 2021-10-14 | Liberty Biosecurity Llc | Polypeptide compositions and uses thereof |
CN113881645A (zh) * | 2020-07-02 | 2022-01-04 | 北京世城双清科技有限公司 | 一种复合酶清洗剂及其应用 |
CN113881516A (zh) * | 2020-07-02 | 2022-01-04 | 北京世城双清科技有限公司 | 一种复合酶清洗剂 |
WO2022047149A1 (en) | 2020-08-27 | 2022-03-03 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
CN112280765B (zh) * | 2020-09-27 | 2021-10-08 | 扬州大学 | 磺基甜菜碱表面活性剂在提高菠萝蛋白酶活性中的应用 |
GB202017605D0 (en) * | 2020-11-06 | 2020-12-23 | Smarti Env Ltd | biocidal Composition |
EP4284906A1 (en) | 2021-01-29 | 2023-12-06 | Danisco US Inc. | Compositions for cleaning and methods related thereto |
CN117616120A (zh) | 2021-06-30 | 2024-02-27 | 丹尼斯科美国公司 | 变体脂肪酶及其用途 |
CN117916354A (zh) | 2021-09-03 | 2024-04-19 | 丹尼斯科美国公司 | 用于清洁的衣物洗涤组合物 |
WO2023039270A2 (en) | 2021-09-13 | 2023-03-16 | Danisco Us Inc. | Bioactive-containing granules |
CN114410610A (zh) * | 2021-12-08 | 2022-04-29 | 自然资源部第三海洋研究所 | 一种环麦芽糊精酶及其制备方法与应用 |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
CN114209818A (zh) * | 2021-12-21 | 2022-03-22 | 苏杰 | 防止和去除牙周生物膜的含水解酶和聚谷氨酸的组合物 |
CN115247106A (zh) * | 2022-01-15 | 2022-10-28 | 郑州大学第一附属医院 | 一种内镜多酶清洗组合物及其应用 |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
BE1030645B1 (fr) * | 2022-06-20 | 2024-01-29 | Realco | Methode de detection de microorganismes |
WO2023247502A1 (fr) | 2022-06-20 | 2023-12-28 | Realco | Composition de decrochage et de prelevement de microorganismes |
BE1030650B1 (fr) * | 2022-06-20 | 2024-01-29 | Realco | Composition de decrochage et de prelevement de microorganismes |
BE1030647B1 (fr) * | 2022-06-20 | 2024-01-29 | Realco | Procede d'echantillonnage de microorganismes sur des surfaces industrielles agro-alimentaires |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
CN117486439B (zh) * | 2024-01-03 | 2024-03-08 | 北京哈泰克工程技术有限公司 | 一种低污泥产率的造纸废水处理方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071765A (en) * | 1989-03-13 | 1991-12-10 | Nalco Chemical Company | Application of multiple enzyme blend to control industrial slime on equipment surfaces |
US5753460A (en) * | 1993-10-08 | 1998-05-19 | Novo Nordisk A/S | Amylase variants |
WO2001066712A2 (en) * | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
US4725544A (en) | 1986-04-25 | 1988-02-16 | Tan Larry U | Method for purifying xylanase |
DK564086A (da) | 1986-11-25 | 1988-06-17 | Novo Industri As | Enzymatisk detergent-additiv |
US4966850A (en) | 1987-01-21 | 1990-10-30 | Forintek Canada Corp. | Production of thermostable xylanase and cellulase |
DE3854249T2 (de) | 1987-08-28 | 1996-02-29 | Novo Nordisk As | Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen. |
DK6488D0 (da) | 1988-01-07 | 1988-01-07 | Novo Industri As | Enzymer |
US5116746A (en) | 1988-03-04 | 1992-05-26 | Institut Armand Frappier | Cellulase-free endo-xylanase enzyme of use in pulp delignification |
WO1990001060A1 (en) | 1988-07-27 | 1990-02-08 | Iowa State University Research Foundation, Inc. | Low molecular weight xylanase glycoprotein |
CA2003503A1 (en) | 1988-11-23 | 1990-05-23 | Roberta Lee Farrell | Use of aureobasidium pullulans in pulp bleaching |
US4936994A (en) * | 1989-03-13 | 1990-06-26 | Nalco Chemical Company | Application of cellulase to control industrial slime |
CA2001538A1 (en) * | 1989-03-13 | 1990-09-13 | Christopher L. Wiatr | Application of glucanase to control industrial slime |
JPH02238885A (ja) | 1989-03-13 | 1990-09-21 | Oji Paper Co Ltd | フェノールオキシダーゼ遺伝子組換えdna、該組換えdnaにより形質転換された微生物、その培養物及びフェノールオキシダーゼの製造方法 |
DK316989D0 (da) | 1989-06-26 | 1989-06-26 | Novo Nordisk As | Enzymer |
DE4023458A1 (de) | 1989-08-31 | 1991-03-07 | Kali Chemie Ag | Neue hochalkalische proteasen |
SE465320B (sv) | 1990-01-10 | 1991-08-26 | Korsnaes Ab | Preparat som uppvisar enzymatisk delignifieringsaktivitet, saett att framstaella detsamma och tillaempningar daerav |
AT394730B (de) | 1990-05-08 | 1992-06-10 | Voest Alpine Ind Anlagen | Verfahren zur herstellung exo- und endocellulasefreier xylanase |
AU7990391A (en) | 1990-06-08 | 1991-12-31 | Valtion Teknillinen Tutkimuskeskus | Beta -xylanase preparation, process for the preparation thereof and its use in pulp bleaching |
WO1991018976A1 (en) | 1990-06-08 | 1991-12-12 | Novo Nordisk A/S | HEMICELLULASES PRODUCED BY $i(BACILLUS STEAROTHERMOPHILUS) |
FI903443A (fi) | 1990-07-06 | 1992-01-07 | Valtion Teknillinen | Framstaellning av lackas genom rekombinantorganismer. |
GB9018426D0 (en) | 1990-08-22 | 1990-10-03 | Sandoz Ltd | Improvements in or relating to novel compounds |
NZ239500A (en) | 1990-08-24 | 1993-08-26 | Novo Nordisk As | Xylanases obtained from bacillus pumilus and use in a lignocellulosic chemical pulping process |
ES2121786T3 (es) | 1990-09-13 | 1998-12-16 | Novo Nordisk As | Variantes de lipasa. |
FR2672066B1 (fr) | 1991-01-25 | 1997-01-31 | Du Pin Cellulose | Traitement enzymatique d'une pate ligno-cellulosique chimique. |
JPH05507441A (ja) * | 1991-02-12 | 1993-10-28 | バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド | 産業水系中の表面からバイオフイルムを除去するかまたは同表面上のバイオフイルムの堆積を防止するための組成物および方法 |
KR100234888B1 (ko) | 1991-04-02 | 1999-12-15 | 한센 핀 베네드, 안네 제헤르 | 크실라나제, 대응하는 재조합 dna 서열, 크실라나제 함유 조성물, 및 조성물의 용도 |
DK69591D0 (da) | 1991-04-18 | 1991-04-18 | Novo Nordisk As | Nye mikroorganismer |
US5858757A (en) | 1991-05-01 | 1999-01-12 | Novo Nordisk A/S | Stabilized enzymes and detergent compositions |
CA2048322A1 (en) | 1991-08-08 | 1993-02-09 | Dieter Kluepfel | Xylanase for biobleaching |
DK175391D0 (da) | 1991-10-18 | 1991-10-18 | Novo Nordisk As | Nye enzymer |
JPH07504807A (ja) | 1991-11-26 | 1995-06-01 | ノボ ノルディスク アクティーゼルスカブ | プロテアーゼ安定性タンパク質 |
DK34892D0 (da) | 1992-03-16 | 1992-03-16 | Novo Nordisk As | Nyt enzym |
JPH07509125A (ja) | 1992-07-02 | 1995-10-12 | ノボザイムス アクティーゼルスカブ | 好アルカリ性バチルス種ac13及びそれより獲得できるプロテアーゼ,キシラナーゼ,セルラーゼ |
ES2316882T3 (es) | 1993-03-10 | 2009-04-16 | Novozymes A/S | Enzimas de aspergillus aculeatus con una actividad xilanasa. |
US5480801A (en) | 1993-09-17 | 1996-01-02 | Novo Nordisk A/S | Purified PH neutral Rhizoctonia laccases and nucleic acids encoding same |
KR100338786B1 (ko) | 1993-10-13 | 2002-12-02 | 노보자임스 에이/에스 | H2o2-안정한퍼록시다제변이체 |
JPH09510617A (ja) | 1994-03-29 | 1997-10-28 | ノボ ノルディスク アクティーゼルスカブ | アルカリ性バチルスアミラーゼ |
EP0758377A1 (en) | 1994-05-03 | 1997-02-19 | Novo Nordisk A/S | Alkaline glucose oxidase |
PT765394E (pt) | 1994-06-03 | 2002-03-28 | Novozymes Biotech Inc | Lacases myceliophthora purificadas e acidos nucleicos que as codificam |
ES2153037T3 (es) | 1994-06-03 | 2001-02-16 | Novo Nordisk Biotech Inc | Lacasas purificadas de scytalidium y acidos nucleicos que las codifican. |
MX9606726A (es) | 1994-06-24 | 1997-03-29 | Novo Nordisk Bitoech Inc | Lacasas purificadas de polyporus y acidos nucleicos que las codifican. |
AU3253695A (en) | 1994-08-26 | 1996-03-22 | Novo Nordisk A/S | Coprinaceae laccases |
JP3025627B2 (ja) | 1995-06-14 | 2000-03-27 | 花王株式会社 | 液化型アルカリα−アミラーゼ遺伝子 |
DE69636754T2 (de) | 1995-07-14 | 2007-10-11 | Novozymes, Inc., Davis | Haloperoxidasen aus curvularia verruculosa und nukleinsäuren, die für diese codieren |
JPH09213868A (ja) | 1996-01-30 | 1997-08-15 | Nec Corp | マイクロ波半導体集積回路用リ−ドフレ−ム |
EP0963618B1 (en) * | 1996-09-30 | 2004-05-06 | Danionics A/S | An electrolyte system, a method for the preparation thereof, the use thereof and a battery containing the electrolyte system |
US6342386B1 (en) * | 1996-10-29 | 2002-01-29 | Warren Paul Powers | Methods for removing undesired growth from a surface |
US6100080A (en) * | 1996-12-18 | 2000-08-08 | Novo Nordisk A/S | Method for enzymatic treatment of biofilm |
US6187576B1 (en) | 1997-10-13 | 2001-02-13 | Novo Nordisk A/S | α-amylase mutants |
AU734737B2 (en) * | 1997-10-17 | 2001-06-21 | Novozymes A/S | Plaque-inhibiting oral compositions |
WO2000022103A1 (en) * | 1998-10-13 | 2000-04-20 | Novozymes A/S | A modified polypeptide with reduced immune response |
US6592867B2 (en) * | 1998-11-09 | 2003-07-15 | Novozymes A/S | Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type |
US6403355B1 (en) | 1998-12-21 | 2002-06-11 | Kao Corporation | Amylases |
BRPI0009362B8 (pt) * | 1999-03-30 | 2019-08-20 | Novozymes As | variante de uma alfa-amilase precursora, e, uso de uma variante de alfa-amilase |
ES2532606T3 (es) | 1999-03-31 | 2015-03-30 | Novozymes A/S | Polipéptidos con actividad de alfa-amilasa alcalina y ácidos nucleicos que los codifican |
US6939702B1 (en) | 1999-03-31 | 2005-09-06 | Novozymes A/S | Lipase variant |
AUPQ679100A0 (en) * | 2000-04-07 | 2000-05-11 | Novapharm Research (Australia) Pty Ltd | Process and composition for cleaning medical instruments |
US6777223B2 (en) * | 2000-06-19 | 2004-08-17 | Novozymes Biotech, Inc. | Methods for eliminating the formation of biofilm |
AUPQ921400A0 (en) * | 2000-08-04 | 2000-08-31 | Canon Kabushiki Kaisha | Method of enabling browse and search access to electronically-accessible multimedia databases |
US7560126B2 (en) * | 2001-02-21 | 2009-07-14 | Verenium Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
AUPS328002A0 (en) * | 2002-06-28 | 2002-07-18 | Novapharm Research (Australia) Pty Ltd | Water treatment |
FR2846665B1 (fr) * | 2002-10-31 | 2006-09-08 | Karine Marion | Procede d'elimination du biofilm |
JP2004231671A (ja) * | 2002-12-03 | 2004-08-19 | Lion Corp | 洗浄剤組成物及び除菌・洗浄力評価方法 |
ES2517245T3 (es) * | 2003-06-25 | 2014-11-03 | Novozymes A/S | Enzimas para el tratamiento de almidón |
-
2005
- 2005-09-07 US US11/574,688 patent/US20080248558A1/en not_active Abandoned
- 2005-09-07 DK DK10180231.2T patent/DK2258836T3/en active
- 2005-09-07 CN CN201210357075.6A patent/CN103182387B/zh active Active
- 2005-09-07 EP EP10180231.2A patent/EP2258836B1/en active Active
- 2005-09-07 CN CN201210357051.0A patent/CN103181400B/zh active Active
- 2005-09-07 WO PCT/US2005/031813 patent/WO2006031554A2/en active Application Filing
- 2005-09-07 EP EP10180241A patent/EP2258837A1/en not_active Ceased
- 2005-09-07 CN CNA2005800300950A patent/CN101040052A/zh active Pending
- 2005-09-07 JP JP2007531293A patent/JP5345781B2/ja not_active Expired - Fee Related
- 2005-09-07 EP EP05795624.5A patent/EP1791966B1/en active Active
- 2005-09-07 CN CN201210356472.1A patent/CN102919273B/zh active Active
-
2010
- 2010-11-29 US US12/955,251 patent/US20110104141A1/en not_active Abandoned
-
2013
- 2013-04-15 US US13/863,030 patent/US20130217099A1/en not_active Abandoned
-
2019
- 2019-01-07 US US16/241,310 patent/US20200181539A9/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071765A (en) * | 1989-03-13 | 1991-12-10 | Nalco Chemical Company | Application of multiple enzyme blend to control industrial slime on equipment surfaces |
US5753460A (en) * | 1993-10-08 | 1998-05-19 | Novo Nordisk A/S | Amylase variants |
WO2001066712A2 (en) * | 2000-03-08 | 2001-09-13 | Novozymes A/S | Variants with altered properties |
Non-Patent Citations (1)
Title |
---|
地衣芽孢杆菌耐高温α-淀粉酶基因在大肠杆菌中的克隆、表达及其产物的分泌;李金霞等;《食品与发酵工业》;20040330;第30卷(第3期);第70-73页 * |
Also Published As
Publication number | Publication date |
---|---|
US20080248558A1 (en) | 2008-10-09 |
CN103181400B (zh) | 2016-08-10 |
CN101040052A (zh) | 2007-09-19 |
JP5345781B2 (ja) | 2013-11-20 |
CN102919273A (zh) | 2013-02-13 |
EP2258836B1 (en) | 2016-05-04 |
US20110104141A1 (en) | 2011-05-05 |
JP2008512468A (ja) | 2008-04-24 |
EP2258837A1 (en) | 2010-12-08 |
CN103182387A (zh) | 2013-07-03 |
CN102919273B (zh) | 2016-03-16 |
WO2006031554A2 (en) | 2006-03-23 |
EP2258836A1 (en) | 2010-12-08 |
US20130217099A1 (en) | 2013-08-22 |
CN103181400A (zh) | 2013-07-03 |
US20190256803A1 (en) | 2019-08-22 |
EP1791966A4 (en) | 2008-12-03 |
EP1791966B1 (en) | 2014-06-04 |
WO2006031554A3 (en) | 2006-09-28 |
US20200181539A9 (en) | 2020-06-11 |
EP1791966A2 (en) | 2007-06-06 |
DK2258836T3 (en) | 2016-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103182387B (zh) | 防止、去除、减少或破坏生物膜的方法 | |
JP5448162B2 (ja) | 酵素を利用したバイオフィルム形成の防止とその制御 | |
US6777223B2 (en) | Methods for eliminating the formation of biofilm | |
US6100080A (en) | Method for enzymatic treatment of biofilm | |
EP2225356B1 (en) | Enzymatic prevention and control of biofilm | |
AU696190B2 (en) | Use of mannanases as slime control agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |